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1.1. The global epidemiology and burden of malaria 
Malaria remains the most important parasitic disease affecting humans, with 
approximately one fourth of the world population at risk of infection. Plasmodium 
falciparum, P. vivax, P. ovale and P. malariae are the four species causing disease in humans. 
P. knowlesi, which naturally infects macaques, is also transmissible to humans in whom it 
may cause disease1-5. P. falciparum is the most pathogenic species. In 2008, an estimated 
243 million clinical malaria cases occurred worldwide, with 863,000  deaths6, the great 
majority (89%) falling on poor rural communities of sub-Saharan Africa6-8. In the same area, 
in addition to the human cost, malaria causes every year an average loss of 1.3% of 
economic growth 9, and represents a major obstacle to the development of disease-
endemic countries10.   
 
1.2. Malaria in Burkina Faso 
Burkina Faso is a landlocked Sahel country in West Africa lying between the Sahara 
Desert and the Gulf of Guinea (Figure 1). Its vegetation ranges from forest in the south to 
semi-desert, Sahel, in the north. The central part has the ecological characteristics of Sudan 
savannah. Annual rainfall varies from about 1,000 mm in the south to less than 250 mm in 
the extreme north11. The country has two distinct seasons, dry from November to May and 
wet from June to October.  
Malaria represents a leading public health problem in Burkina Faso12,13. P. falciparum is the 
predominant plasmodial species and accounts for 90% of the infections; the remainder is 
attributed to either P. malariae (8%) or P. ovale (2%). The main malaria vectors are 
Anopheles gambiae s.l. and An. funestus14. Children and pregnant women are the most 
vulnerable groups at risk of malaria-related morbidity and mortality.  
Rural families, that account for 80% of the population, are the least likely to have access to 
malaria control measures, since they live far from the nearest health facility and less able to 
afford treatment 15.  
The climatic features during the wet season (high temperature and humidity) allow for 
excellent synchronization between the vector’s multiplication and long life-span 16-18 with 
the parasite’s replication in both vector and human hosts, together conferring a high 
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reproduction rate to P. falciparum 17 in the country. Malaria transmission differs, 
nevertheless, characterized as unstable in the extreme north but perennial in the south. In the 
central plateau, where it is holoendemic 19, transmission is stable and seasonal with an 
entomological inoculation rate (EIR) with peaks of 300-500 infective bites/person/year20 
during the wet season but effectively close to zero during the dry season. The prevalence of 
P. falciparum infection has been estimated to be approximately 90% in children below 5 
years of age in the year of 200421,22. 
 
 
Figure 1: Malaria transmission characteristics in Burkina Faso  
 
1.3. The biology of P. falciparum 
The asexual blood forms of P. falciparum  are responsible for malaria-related morbidity and 
mortality, whilst transmission of the parasite  depends on the presence of sexual forms 
(gametocytes) in human blood that can infect anopheline vectors. 
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The life cycle (Figure 2) of P. falciparum can be depicted as starting when an infected female 
Anopheles mosquito bites a human being, when sporozoites are inoculated and can enter 
the blood stream. 30% of the sporozoites leaving the skin bite area are estimated to invade 
the lymph nodes 23-25 whilst the remainder migrates to the liver. There, they invade and 
mature within hepatocytes, each sporozoite undergoing asexual reproduction to produce 
several thousand merozoites. The hepatocyte bursts and the merozoites thereby released 
invade red blood cells (erythrocytes) where they feed on haemoglobin and mature into 
trophozoites. Nuclear division ensues in an asexual reproductive cycle (erythrocytic 
schizogony) that leads to the formation of schizonts that comprise a collection of individual 
merozoites. After subsequent release and reinvasion of an erythrocyte, a fraction of these 
merozoites develop into individual male and female gametocyte sexual forms that are 
ingested by a female Anopheles mosquito taking a blood meal. In the mosquito midgut, the 
gametocytes mature into gametes that, after fertilization, form a motile zygote that matures 
into an ookinete and, ultimately, an oocyst on the mosquito midgut wall. Within each 
oocyst, hundreds of sporozoites develop, eventually rupturing the oocyst and migrating to 
the mosquito salivary glands from where they can be inoculated into the skin of the next 
human on whom the mosquito feeds.  
 
 
 
Figure 2: Life cycle of P. falciparum 
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1.4. Malaria control and elimination 
 
1.4.1. History of malaria control 
Early initiatives aimed at malaria control in the 1950s and 1960s, coordinated by the Global 
Malaria Eradication Campaign, recommended malaria case management and the use of 
dichlorodiphenyltrichloroethane (DDT) for indoor spraying of dwellings against the 
mosquito vector as major strategies to reduce the burden of malaria. The programme was 
successful in low and unstable transmission areas of North America and Europe26. Sub-
Saharan Africa, which needed a long-term integrated programme, was excluded from this 
campaign because of economic instability and various other issues. In some areas like Sri 
Lanka, India and Cambodia, attempts to eliminate malaria were followed by disastrous 
increases in transmission once enthusiasm was lost and interventions were abandoned27. 
After this period, efforts to control malaria have been purely initiated on a bilateral basis or 
through international organizations. In 1992, the Global Malaria Control Strategy was 
adopted in Amsterdam and focused on prompt diagnosis, treatment and preventive 
measures. This was followed in 1996 by establishment of the Multilateral Initiative on 
Malaria that aimed to link the global malaria research community and strengthen research 
capacity in malaria endemic countries. In 1997, the Organization for African Unity called 
upon international organizations to give malaria greater priority.  
 
1.4.2. Current malaria control strategies 
In 1998 the Roll Back Malaria (RBM) Partnership was initiated to coordinate efforts 
in malaria control. The main goal of the RBM was to ensure a reduction in the burden of 
malaria of at least 50% by 2010 and of 75% by 2015, moving towards elimination in some 
countries 28.  
The global strategy of the RBM Partnership is based on prevention and treatment through i) 
the use of long-lasting insecticide-treated nets (LLINs), ii) early diagnosis and timely seeking 
of appropriate treatment with artemisinin-based combination therapies (ACTs), iii) 
intermittent preventive treatment (IPT) during pregnancy and iv) indoor residual spraying 
(IRS) with insecticides to target indoor-resting mosquitoes.  
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1.4.3. Current effective tools for malaria prevention and treatment 
LLINs are currently one of the most important tools for vector control. With a 
lifespan exceeding 3 years6, they can not only reduce vector-human contact, but mosquitoes 
are also killed by the insecticide. LLINs have been shown to significantly reduce childhood 
malaria-related morbidity and mortality in malaria endemic areas29,30. Despite calls for a 
rapid scaling up of LLINs coverage by RBM in 2002, only an estimated 20% of children at risk 
in sub-Saharan Africa had received an LLIN by 200731.  
IRS consists of the application of insecticides to the inner surfaces of dwellings, where 
endophilic anopheline mosquitoes often rest after taking a blood meal. IRS can be effective 
in reducing malaria transmission by killing / repelling mosquitoes and, subsequently, 
reducing morbidity and mortality32. However, caution is needed as resistance to insecticides 
may develop, especially pyrethroids6. In 2008, nineteen countries in the African Region, 
reported implementing IRS6.  
Intermittent preventive treatment (IPT) is recommended for women during 
pregnancy to prevent malaria that can lead to maternal anemia and placental infection that 
itself is associated with low birth weight babies33-37. WHO currently recommends that at 
least 2 doses of SP be administered as a prophylaxis after the first trimester during 
antenatal care6.  
 
1.4.4. Malaria diagnosis  
Because preventive measures are not fully effective, early malaria diagnosis and effective 
treatment form important components of malaria control. 
Although clinical diagnosis of malaria is imprecise, it remains the basis of therapeutic 
care for the majority of febrile patients in malaria endemic areas, where laboratory facilities 
are often limited. To avoid over prescription of ACTs, the WHO has recommended the use of 
a parasitological test before treating38. Rational treatment of malaria is essential both to 
avoid non-target effects, to delay the advent of resistance, and to save cost on alternative 
drugs.  
For the diagnosis of clinical malaria attacks and quantification of clinically relevant 
parasite densities in the blood, microscopy is the most affordable and widely-used 
technique 39. Microscopy can be used to detect and quantify malaria parasites in a thick 
blood smear by examining multiple (commonly 100) high power fields. Most often, parasites 
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are quantified by simultaneously enumerating the number of leukocytes per microscope 
field and then converting to parasite numbers per μl by assuming a standard 8000 
leukocytes/μl blood. Depending on the number of leucocytes counted the detection limit of 
microscopy ranges between 5-20 asexual stage parasites/ l of blood and 8-16 
gametocytes/ l of blood. Methodological studies of malaria microscopy have documented 
that the frequency of false-positive and false-negative results is remarkably high,  
increasesing markedly at lower parasite densities40,41, and estimates of parasite densities 
may differ between individual microscopists by as much as an order of magnitude42. 
Rapid Diagnostic Tests (RDTs) are immuno-chromatographic tests with plasmodial 
antigen specificity43-45. RDTs were introduced as an alternative to microscopy in health 
settings lacking laboratory facility. Although RDTs have an important impact on clinical 
decisions46, they have limitations including low sensitivity6,47, absence of quantification, lack 
of parasite stage specificity, as well as cost. 
 
1.4.5. Artemisinin-based combination therapies (ACTs) 
Chloroquine (CQ) and sulphadoxine-pyrimethamine (SP), long considered the most effective 
and useful anti-malarial drugs, have become largely  ineffective as monotherapy for the 
treatment of P. falciparum malaria in sub-Saharan Africa, with increases in malaria-related 
morbidity and mortality thought to be one of the primary consequences48. In recent years, 
following the RBM partnership recommendations, malaria treatment policies have thus 
shifted in most sub-Saharan countries to ACTs for the treatment of uncomplicated P. 
falciparum malaria38. 
Artemisinin-based combination therapy comprises the simultaneous use of an artemisinin 
component with one or more drugs that have independent modes of action and different 
biochemical targets in the parasite, thereby offering faster cure rates with the (theoretical) 
additional advantage of delaying the development of resistance to the partner drug for a 
much longer time period. Four combinations are currently recommended: artesunate-
amodiaquine, artemether-lumefantrine, artsunate-mefloquine, and artesunate-sulfadoxine-
pyrimethamine45.  
ACT acts as a double-sword by providing a complete cure of the infection, as well as 
reducing transmission49-52, thereby eliminating the sources of new malarial infections49,53 
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However, ACTs are much more expensive than previous regimens and coverage with ACTs in 
sub-Saharan Africa is still extremely low. Only 3% of children under 5 years of age received 
ACTs in 2006 and 200754. In Burkina Faso, ACTs were adopted as first-line treatment in 
200555, after childhood mortality was found to have increased due to CQ resistance56-62. 
ACTs became widely available in 2007 in Burkina Faso15 with artemether-lumefantrine (AL) 
and artesunate-amodiaquine (AS/AQ) available for treatment of uncomplicated malaria. 
Sulpfadoxine/pyrimethamine (SP) is used for intermittent preventive treatment during 
pregnancy.  
 
1.4.6. Vaccines as additional tools for controlling malaria 
History teaches us that malaria control interventions lead to often unmet 
expectations and that the real picture is one of increasingly more widespread drug-resistant 
parasites and insecticide-resistant vectors. In this context, and as part of the global efforts 
to control malaria, effective vaccines will be of great importance. The clinical protection 
provided by immunity acquired through natural repeated exposure63 or by immunization 
with either irradiated64 or viable sporozoites while under effective prophylaxis 65 suggest 
that a malaria vaccine is indeed feasible.  
Vaccines against pre-erythrocytic stages or asexual blood stages aim to prevent 
infection or prevent/reduce (severe) clinical disease. Although several vaccine candidates 
are in the pipeline of clinical trials, the most advanced is the so-called RTS,S vaccine, 
developed originally by GSK and the US Army, which has shown up to 65% efficacy against P. 
falciparum infection and is now in multi-centre Phase 3 trials  sub-Saharan across  Africa66-68.  
Malaria vaccines can also target a third life stage, the transmission stage. The so-
called transmission blocking vaccine is directed against the parasite’s mosquito stages 
through induction of human immune responses that interfere with sporogonic development 
in the mosquito midgut, thereby reducing or interrupting transmission69-76. A transmission 
blocking vaccine will reduce the number of infected mosquitoes and is thus predicted to 
subsequently reduce population-wide malaria infection rates and ultimately malaria-
associated morbidity/mortality. Its viability is supported by observations of naturally 
acquired transmission reducing immune responses in endemic situations. 
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1.4.7. Naturally-acquired and vaccine-induced transmission reducing activity 
(TRA) 
Transmission reducing immunity was first reported in the 1970s in immunized 
chickens77,78 and later using specific monoclonal antibodies 73,79-81 or naturally acquired 
antibodies72,73,75,82-86 against sporogonic stages. Transmission reducing activity (TRA) in the 
mosquito midgut mostly depends on human humoral (antibody-mediated) immunity rather 
than cellular components87,88. Transmission reducing antibodies may prevent fertilization by 
blocking the fertilization receptors on gametes, by a complement-mediated lysis of gametes 
and zygotes or by preventing ookinete invasion of the midgut epithelium89. Transmission 
reducing antibodies are ingested as part of the blood meal of the anopheline vector, 
inhibiting the development of sporogonic stages resulting in the prevention of malaria 
transmission to another human. In endemic areas, natural transmission reducing immunity 
develops after exposure to gametocytes that have a finite lifespan and die if not transmitted 
to a mosquito. Effective immunity of this type is generally induced in individuals with little 
or no history of malaria, either young African children or travellers from non-endemic 
areas69. It is thought to be short-lived90 in contrast to immune responses that protect 
against the pre-erythrocytic and/or asexual blood stages, immunity that is comparatively 
long-lived once acquired and that correlates positively with repeated exposure91,92.  
The most reliable methods to assess TRA are formed by experiments in which gametocytes 
are offered to mosquitoes. Different mosquito feeding assays can be used to measure 
transmission from man to mosquito: i) in the skin feeding assay93-95, mosquitoes directly 
feed on a human volunteer but the subject’s safety and outcomes of mosquito infection 
may be considered controversial if the mosquitoes used in the experiment are not reared 
under sterile conditions, raising ethical concerns; ii) in the direct membrane feeding 
assay96,97, mosquitoes feed on whole blood sample offered through an artificial membrane; 
iii) in the standard membrane feeding assay70,98,99, which is gold standard for transmission 
blocking activity measurement, gametocytes obtained from parasites cultured are mixed 
with test or control serum and offered to mosquitoes through an artificial membrane. By 
microscopic observation of the mosquito midgut 7 to 9 days later, the presence or absence 
of oocysts determines the human infectiousness.   
In addition to mosquito feeding assays, serological tests (ELISA) can be used to measure 
gamete surface antigen-specific antibodies in serum as a surrogate marker for TRA69,72-74,83. 
 General introduction 
16 
 
The targets of transmission reducing immunity are the extracellular (surface membrane-
expressed) antigens of the sporogonic stages. These include, for example, Pfs48/45 , a pre-
fertilisation protein expressed on P. falciparum gametocytes and gamete surfaces that has a 
central role in male gamete fertility100. Recently, expression of a truncated form of Pfs48/45 
(Pfs48/45-10C) produced in E. coli was shown to be able to induce antibody-mediated 
transmission blocking immunity in mice. In a standardized laboratory assay, the antibodies 
reduced P. falciparum oocyst numbers by up to 100% in laboratory-bred female An. 
stephensi101.  
Pfs230 is another protein expressed on the surface of gametocytes that induces natural 
transmission blocking antibodies that act by lysing gametes in the presence of 
complement80,85,102.  
Pfs25 is a post-fertilization protein expressed on the surface of zygote/ookinete.  Antibodies 
against Pfs25 can also reduce transmission103,104 but are not naturally induced in humans.  
The protein is not expressed in gametocytes and therefore not encountered by the human 
immune system.  Pfs25 is one of the leading candidates for development of a transmission 
blocking vaccine. A Phase 1 human trial of a Pfs25-based vaccine showed that functional 
antibodies coud be elicited105 but the trial was interrupted due to adverse events induced by 
the vaccine adjuvant. 
Antibodies directed to Pfs48/45 detected in Cameroonian sera have been shown to be 
associated with TRA75,83 while TRA observed in sera from Papua New Guinea correlated with 
the amount of anti-Pfs230 antibodies. In general, many questions remain about the 
functionality of sexual stage immune responses and their acquisition in relation to exposure 
to (low density) infections.  
  
1.4.8. Microscopical and sub-microscopical parasite densities and malaria control 
and elimination 
At any given moment, only a small fraction of the asexual blood-stage parasites of P. 
falciparum will generate gametocytes106, and as a result only a fraction of infected 
individuals will carry gametocytes106,107 that are estimated to survive  from 1 week107-109 to 
several months108,110 in asymptomatic individuals. In areas where malaria is highly endemic, 
the prevalence of gametocytes circulating in peripheral blood is higher in children, the age-
group that also carries the highest densities of their precursors, the asexual blood-stage 
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parasites93,111,112. In areas of low endemicity, the distribution of gametocytes is evenly 
spread across age-groups107,113. In both cases, the patterns of gametocytes reflect those of 
asexual blood-stage parasites that are themselves a  reflection of transmission intensity and 
naturally-acquired immunity. The low occurrence of gametocytes in endemic areas is also 
partly a reflection of the low sensitivity of microscopy for their detection  especially since 
they often circulate at very low densities114-117. More recently, molecular detection methods 
have been developed to detect gametocyte densities below the microscopical threshold.  
Molecular techniques based on RNA quantification are more sensitive than microscopy. The 
reverse transcriptase polymerase chain reaction (RT-PCR) can detect different 
developmental stages of P. falciparum blood stage parasites based on stage-specific gene 
expression 118. The use of RT-PCR has proved that submicroscopic gametocytaemia is 
common in endemic areas119,120. Gametocyte prevalence determined by RT-PCR in a low 
transmission area of Sudan was found to be between 2.5 and 4.5 fold higher than estimates 
by microscopy121. However, a limitation of RT-PCR is that the presence of DNA in malaria 
blood samples may interfere with RNA, negatively affecting amplification accuracy. An 
alternative molecular technique is quantitative nucleic sequence-based amplification (QT-
NASBA). QT-NASBA122 is based on the activity of three enzymes (AMV-RT, Rnase H and T7 
RNA polymerase) and the use of two target-specific primers (one of which includes a T7 
polymerase/promotor) to amplify RNA molecules at a low temperature of 41°C, restricting 
annealing to single strand RNA alone and not to DNA. QT-NASBA has been adapted for 
simple use in the field and parasitic ribosomal and messenger RNA has been found to be 
stable for at least two months when bound to silica and stored dry at -20° C. The technique 
allows parasite quantification to be performed using small-volume (50- 100 µl) finger prick 
blood samples, and has a lower limit of 10 asexual parasites/mL and 20-100 
gametocytes/mL. Studies in malaria endemic areas of East and Central East Africa have 
shown that submicroscopic gametocyteamias quantified by QT-NASBA is common in 
asymptomatic children, but also at enrolment and after treatment of symptomatic 
children123-125. Sub-microscopic gametocyte carriers in both treated and asymptomatic 
groups were able to infect mosquitoes in membrane feeding experiments49,126, highlighting 
the importance for malaria control efforts of more sensitive molecular techniques as 
potentially valuable tools in determining the true reservoir of infection.  
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Effectively attacking malaria would indeed benefit from better knowledge of the 
human infectious reservoir since the more precise the estimates, as well as their relative 
contribution to transmission, the more efficient will be the interventions, leading to more 
effective control and, ultimately, faster elimination.  
 
2. Decline in the burden of malaria 
In recent years a substantial decline in the burden of malaria has been reported by 
several countries in sub-Saharan Africa127. Most of these countries showed an overall 50–
90% decline in the prevalence of malaria128-135. Although these findings have resulted in 
optimism about the possibilities to reduce the burden of malaria with currently available 
tools136, caution is needed when considering the challenges of controlling or eliminating 
malaria. No reduction or even increases in the burden of malaria has been  registered in 
countries such as Burkina Faso or Nigeria despite an increase in bed net coverage137,138 in 
countries with similar characteristics of malaria transmission like Nigeria. The observed 
decline in the burden of malaria in some of the countries is probably the result the WHO 
scaling up malaria control strategies. However, transmission reducing strategies would 
probably bring this much more down as new visions of eliminations highlight their 
importance.  
 
3. Outline of this thesis 
This thesis describes, in several steps, the prevalence of P. falciparum gametocytes and their 
infectiousness in an endemic area with seasonal malaria transmission: i) The within-host 
dynamics of P. falciparum gametocytes ii) The contribution of submicroscopic 
gametocytaemia to malaria transmission, iii) The relevance of sexual stage immunity to 
reducing malaria transmission.  
The dynamics of gametocytes in the human host was studied through a series of cross-
sectional surveys including individuals of all ages. Gametocytes were detected by standard 
microscopy on thick blood smears collected during distinct transmission seasons and the 
effect of age and season tested (Chapter 2). To get more insights in the effect of age on 
gametocytes, a more sensitive molecular technique for parasite quantification was further 
used (Chapter 3 & 4). As infectiousness of P. falciparum within the human host is a key 
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determinant for man-mosquito transmission, membrane feeding experiments were 
performed on malaria exposed individuals where whole blood samples were offered to 
locally reared An. gambiae mosquitoes to test the capacity of gametocyte-carrying humans 
to transmit malaria (Chapter 5). Specific immune responses against P. falciparum sexual 
stages are thought able to reduce man-mosquito transmission. In Chapter 6, the 
epidemiology of naturally acquired immune responses to sexual stages is studied. The 
implications of the overall results for malaria control and elimination are discussed.      
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Summary  
Gametocytes are the malaria parasite stages that secure the transmission from the 
human host to the mosquito. Identifying natural parameters that influence gametocyte 
carriage contribute to a better understanding of the dynamics of the sexual stage parasites 
for transmission reducing strategies. A total of 3400 blood slide readings were done during 4 
cross sectional surveys (2002-2003) including all age groups to determine the effect of 
season on Plasmodium falciparum gametocytes in a seasonal malaria transmission area of 
Burkina Faso. Entomological data were collected to determine the malaria transmission 
intensity in relation to seasons. Transmission intensity was estimated by monthly EIRs, 
averaging 28 and 32 infective bites/person/month in the wet seasons of 2002 and 2003 
respectively. The EIR in the dry seasons was below one infective bite/person/ month.   
The gametocyte prevalence was significantly higher at the start and peak of the wet season 
compared to the dry season when corrected for asexual parasite density and age. 
Gametocyte density significantly increased during the wet season after correction for 
asexual parasite density and age. In this study, season appears to be an independent 
parameter that determines gametocyte prevalence and density and should be considered to 
be included in epidemiological studies on malaria transmission.    
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Introduction  
Plasmodium falciparum is the most pathogenic specie of human malaria and an 
important cause of childhood morbidity and mortality in sub Saharan Africa. Gametocytes 
are the parasite stages that do not cause clinical disease, but are responsible for the 
transmission from the human host to the mosquito. In malaria transmission areas, the effect 
of climatic features on vectorial capacity may lead to a variation of transmission intensity 
and subsequently on the epidemiology of the malaria infections. In some areas, season-
related patterns were demonstrated in prevalence of asexual parasites1,2 and in 
gametocytes3-5. The general goal of these studies was to identify natural factors that are 
associated with changes in the malaria parasite prevalence as they serve as base-line data 
for possible interventions. The only and little detailed study conducted in Burkina Faso on 
transmission showed a slight variation in gametocyte prevalence between the wet and the 
dry season6 and concluded that this variation could not be used for transmission control. 
The objective of the present study was to determine P. falciparum gametocyte prevalence 
and density in Burkina Faso in relation to season. We have thus analyzed the relationship 
between entomological and parasitological parameters in two different seasons (wet and 
dry) in a rural area. 
 
Material and Methods  
Study area and population 
The study took place in 2002 and 2003 in two rural zones of Burkina Faso. Three villages 
were selected from each zone based on their proximities and a recent evidence of high 
malaria endemicity. The distance between zones is about 30 km. Both zones are located 30 
km north and northwest of Ouagadougou, the capital. The distance between villages inside 
each zone varies from 1 to 5 km. All together, these villages are situated in a Sudanese 
savannah area with a marked wet season from June to October. Malaria transmission in the 
area is stable and markedly seasonal. The average entomological inoculation rate (EIR) is 
estimated 300-500 infective bites/person/year7 peaking during the rainy season. P. 
falciparum is the predominant malaria species in the region, accounting for 90% of the 
infections; the remaining 8% and 2% are attributed to P. malariae and P. ovale, 
respectively8. 
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Populations belong to the Mossi tribe and are predominantly subsistence farming 
communities. We first performed a complete census, which showed that there were 2767 
residents in the six villages, each of comparable size and with similar age distributions. The 
census sizes were 348, 333, 494, 488, 680 and 424 in village 1 to 6, respectively. 
Participation of villagers to the Study followed an enrolment procedure at which the first 
subjects that came were enrolled in the study. We performed a sample sizes calculation 
using STATA 9.0 (Stata Corporation, Texas, USA) with pre-existing data on gametocyte 
prevalence in Burkina Faso6. A sample size of 76 subjects per age group (1-4, 5-9, 10-14, 15-
24 and 25+ years) would allow over 85% power to detect a decrease from 23% of 
gametocyte prevalence in children under 5 to 5% in adults above 25 years with a type 1 
error of 0.05. To correct for unexpected missing data, a minimum number of 120 individuals 
/ age group (pool of 20 individuals / age group / village) was thus included in the sample at 
each cross sectional survey to allow a statistically robust testing between age groups. 
Furthermore, we combined the five age groups into three age groups to increase the power 
of the study.  
The study was approved by the Ministry of Health of Burkina Faso. Villagers were informed 
about the purpose of the study and their consent was obtained. Benefits for the participants 
were free treatment for malaria and other common infections. In addition, protective 
means (insecticide treated bed nets) were given to volunteers that allowed the indoor 
mosquitoes collection from their houses. All participants with fever (axillary temperature 
37.5°C) were treated with chloroquine according to the current national policy during the 
study period (2002-2003). Participants diagnosed with severe infections other than malaria 
were treated with antibiotics or offered transport to a medical centre when needed. 
Entomologic data collection 
The main malaria vector in the study area is the complex Anopheles gambiae s.l., with An. 
funestus contributing less to transmission9. Two men per village were recruited and trained 
for assistance in mosquito collection. CDC light trap captures were carried out within the six 
villages to estimate the entomological inoculation rate (EIR) as described by Cuzin-Ouattara 
and collaborators7. This design of indoor mosquito collection covered all time points of the 
parasitological studies. One cross sectional survey was carried out in the dry season of 2002 
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from 19th to 30th March in 16 randomly selected houses of each village. Two longitudinal 
surveys were carried out from June to November 2002 and from April to September 2003. 
Each month, the mosquito collections were carried out in 16 randomly selected houses per 
village. These houses were each made of one room and inhabited by one person, a male 
adult or teenager, who slept under a non-impregnated bed net that we supplied. The CDC 
light trap was placed close to the bed. A monthly mosquito collection was completed per 
village within 4 weeks at the rate of 4 house captures per week. Field workers always 
returned to the same 16 houses, every month. Indoor mosquito capture was done on one 
day per house from 7:00 pm to 6:00 am. Mosquito species were identified morphologically, 
counted and stored in tubes with silica gel. The total density of An. gambiae was divided by 
the number of days of capture to define the daily biting rate per village assuming that each 
female captured by CDC light trap had a drive for biting. The monthly biting rate was 
estimated by multiplying the daily biting rate with the number of days in the month. A 
representative sample of An. gambiae mosquito thoraces and heads were examined for P. 
falciparum circumsporozoite protein (CSP) positivity index using CSP 2-site ELISA10. The 
monthly sporozoite rate was estimated, testing a maximum of randomly selected specimens 
of An. gambiae from each village. The monthly sporozoite rate for each year was obtained 
by dividing the monthly number of positive mosquitoes in ELISA on the number of 
mosquitoes tested. The monthly Entomological Inoculation Rate (number of infectious bites 
per person-time unit) was calculated as the product of the monthly biting rate and the 
monthly sporozoite rate. The uninfected biting rate was obtained by subtracting the number 
of infective bites per person-month from the monthly biting rate.  
Data on seasons and rainfall were obtained from the Direction de la Météorologie 
Nationale, Ministère des Transports, Burkina Faso. 
Parasitological data collection 
Cross sectional surveys were performed at 3 monthly intervals, at the start of the wet 
season (May 27th -June 05th 2002), the peak wet season (August 19-24th 2002), the end of 
the wet season (December 2 -13th 2002) and the dry season (April 14-19th 2003). At each 
cross sectional survey, all adults and children of both sexes initially recorded in the census 
file that arrived at our location (a usual gathering place, not a health centre) were 
systematically included in the study. Thick and thin blood films were both made on the same 
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slide from finger prick blood, and air-dried. Villagers with fever (axillary temperature 
37.5°C) were immediately treated with chloroquine according to the national policy. The 
four surveys conducted by our technical staff resulted in 3400 blood samples.  
At the CNRFP laboratory, the thick smear was stained with 5% Giemsa for 35 minutes. One 
hundred high power fields per thick smear were examined for malaria parasites. Two 
microscopists read each slide sample independently and the mean density was considered. 
A third reader was involved when the difference between the readers exceeded 30% and in 
such a case the median reading was used. Trophozoite and gametocyte densities were 
assessed by counting against 500 leukocytes of blood and converted to counts per µl by 
assuming a standard count of 8000 leukocytes/µl blood. A slide was considered negative if 
no parasite stages were found after examination of 100 fields. 
Data analysis 
Data were double entered by 2 independent data clerks and were compared for typing 
errors. The number of missing values was very low (< 0.5%). Analyses of data were 
performed using SPSS version 12.01 (SPSS Inc., Chicago, IL, USA). Parasite densities of 
positive individuals were analyzed after log-transformation. Geometric mean densities and 
medians were calculated. The distribution of positive densities of log-transformed densities 
of gametocyte- and asexual parasite was tested for normality using the Kolmogorov-
Smirnov test.  
Seasonal patterns were analyzed using the dry season survey as a reference category for the 
other three surveys. Unadjusted (crude) values of odds ratios and of the regression 
coefficient determine the effect of season on gametocytes dependent of age and asexual 
parasite density as selected potential confounding factors. Gender was left out as variable, 
because it did not influence the analysis outcome. Gametocyte prevalence and gametocyte 
density were used as dependent variables. Season, age and log asexual parasite density 
were used as independent variables. Adjusted values of odds ratios and regression 
coefficient (β) were calculated using a logistic and linear regression model to determine the 
specific effect of season on gametocyte prevalence and log density, independent of age and 
asexual parasite density.  In these models, the effect of age was assessed after 
categorization into groups 1-4 years, 5-14 years and 15 years. Odds ratios and regression 
 Chapter 2    
32 
 
coefficients were calculated with 95% confidence intervals (95% CI). Comparison of parasite 
densities was performed using the Student’s t-test for normally distributed data and the 
Mann-Whitney U Test in case of data not conforming to a normal distribution.   
Contrarily to gametocyte prevalence and density and asexual parasite density measured at 3 
monthly intervals time points (cross sectional surveys) at an individual based level, 
entomological data were longitudinally collected from a representative set of houses to 
describe seasonality of malaria transmission in the area. Consequently, our data on 
entomology were not included in regression analyses for predicting gametocyte prevalence, 
but were used to support effects of seasons on gametocytes independently of individual 
based variables as age and asexual parasite density. 
Results 
Entomological and parasitological parameters 
The weather in our study area was characterized by a clear seasonality with peak rainfall 
between June and September (figure 1A). The biting rate, the sporozoite rate and EIR 
calculations were based on A. gambiae. Representative samples of 4,593 and 3,569 female 
An. gambiae (approximately half numbers of total mosquitoes collected) were tested to 
estimate transmission intensity in 2002 and 2003 respectively. All entomological parameters 
are shown in Figure 1B. Transmission intensity quantified by the number of infectious bites 
(EIR) peaked one month after the peak rainfall (Figure 1A, 1B).  
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Figure 1.  A: Mean monthly rain fall in 2002 and 2003. B: Mean number of bites 
/person/month (total bites), mean number of infective bites /person/month (EIR), mean 
number of uninfected bites /person/month (Uninf bites), monthly sporozoite rate (Spor 
rate) in 2002 and 2003. Arrows indicate cross-sectional surveys for parasitological data collection. 
A total of 10,262 mosquitoes were longitudinally captured from the start to the end of the wet 
season 2002 and showed 9,785 An. gambiae versus 477 An. funestus. From the dry season to the 
peak wet season 2003; 6,044 An. gambiae were captured versus 445 An. funestus.  
 
The entomological cross sectional survey carried out during the dry season in March 2002 
resulted in the capture of 8 An. gambiae mosquitoes. A total of 68 uninfected An. gambiae were 
captured in April in the dry period of 2003 and 0 in May 2003. Infectious mosquitoes were not 
collected in both dry seasons. While the exposure to infectious bites at the start of the wet 
season was low, exposure to uninfected mosquito bites was elevated to 32 and 200 
mosquito bites per person per month at the start of the wet season (June) in 2002 and 
2003, respectively  (Figure 1B).  
During the entire study period, P. falciparum asexual or sexual stages were microscopically 
detected in 61.8% (2,100 of 3,400 blood slides). Only asexual parasites were detected in 
43.4% (n = 1477); asexual parasites and gametocytes in 14.8% (n = 503) and only 
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gametocytes in 3.5% (n = 120). Of the children under 5 years of age 71.3% (452/634) and 
27.9% (177/634) carried asexual parasites and gametocytes, respectively. In subjects >30 
years only 23.5% (160/682) and 5.3% (36/682) carried asexual parasites and gametocytes, 
respectively. The negative association between age in years and parasite prevalence was 
statistically significant for both asexual parasites (OR = 0.94; 95% CI 0.94 – 0.95) and 
gametocytes (OR = 0.95; 95% CI 0.95 – 0.96).  
Season and asexual parasites 
Asexual parasite prevalence showed a marked seasonality (Figure 2A). Compared to the dry 
season, asexual parasite prevalence was significantly elevated at the peak (OR = 3.90, 95% 
CI 3.12-4.86; p<0.001) and end (OR = 2.31, 95% CI 1.84-2.91; p<0.001) of the wet season, 
after adjustment for age. The geometric mean of positive parasite densities was markedly 
different between the age groups at any period of the year (Figure 2B). The parasite density 
was highest at the peak of the wet season and decreased towards the end of the wet 
season. This lower asexual parasite density at the end compared to the peak of the wet 
season was significant for children aged 5-14 years (t = 3.889; df = 521; p<0.001) but not for 
adults of 15 years (t = 1.814, df= 219; p = 0.07) and children below five years of age 
(t=1.05; df= 228; p = 0.3). 
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Figure 2: Plasmodium falciparum asexual parasite prevalence (A), density (B) and 
gametocyte prevalence (C) and density (D) in relation to season in different age group, (x) 
= 1-4 years; ( ) = 5-14 years; (+) = 15+ years. The error bars show the ± limits of the 95% 
confidence intervals.  The number of blood samples collected at the start, peak and end of the wet 
season in 2002 was 968, 749 and 599, respectively. During the dry season 2003, 1084 samples were 
collected. Densities concern positive cases only.  
Season and gametocytes 
Gametocyte prevalence was positively associated with log-transformed asexual parasite 
density (OR 1.17; 95% CI 1.05 – 1.31) and was also elevated in the wet season (Figure 2C). 
Gametocyte prevalence was significantly higher at the beginning and the peak of the wet 
season, as compared to the dry season, after adjustment for age and asexual parasite 
density. In contrast, gametocyte prevalence appeared to be somewhat lower at the end of 
the wet season (Table 1).  
Densities of gametocytes were 1-2 logs lower than asexual parasites with no consistent 
difference between age groups (Figure 2D). The median of gametocyte density was 24 (IQR 
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16-40) gametocytes/µl at the start of the wet season, 32 (IQR 16-64)  at the peak of the wet 
season,  40 (IQR 36-56) at the end of the wet season and  24 (IQR 16-32) in the dry season.  
There was no difference in the gametocyte density between the start of the wet season and 
the dry season (p = 0.48, Mann-Whitney U Test). It was significantly higher at the peak and 
end of the wet season compared to the dry season (p<0.001 and p<0.001 respectively, 
Mann-Whitney U Test).  
 After adjustment for age and asexual parasite density, gametocyte density was significantly 
higher at the peak and end but not at the beginning of the wet season, when compared to 
the dry season (Table1). Despite these seasonal differences in low gametocyte densities, the 
prevalences are more robust, particularly at the start of the transmission season. 
Table1: Crude (unadjusted) and adjusted effect of season on gametocyte prevalence and 
density 
 
 
Gametocyte     
prevalence                    n/N                Crude OR (95% CI)         P-value       Adjusted OR (95% CI)
a          
P-value 
 
Start wet season       201/968        1.62 (1.28 – 2.04)        <0.001       1.81(1.36-2.42)                <0.001 
 
Peak wet season       188/749        2.07 (1.63 – 2.62)        <0.001       1.75 (1.30-2.35)               <0.001 
 
End wet season         83/599          0.99 (0.75 – 1.33)          0.97          0.68 (0.48-0.96)                 0.03 
 
Dry season                 151/1084      1.0b                                                                                 1.0b 
 
Gametocyte   
density                           Mean
c 
(n)        Crude  (95% CI) 
                   
P-value       Adjusted  (95% CI)
a                 
P-value 
 
Start wet season      28.3 (201)      0.04 (-0.027 – 0.107)   0.24          0.014 (-0.064 – 0.092)      0.73 
 
Peak wet season      37.6 (188)      0.164 (0.10 – 0.23)     <0.001       0.109 (0.028 – 0.189)       0.008 
 
End wet season        45.1 (83)        0.243 (0.16 – 0.33)     <0.001       0.152 (0.053 – 0.251)       0.003 
 
Dry season                25.8 (151)       0.0b                                                    0.0b 
 
OR =  Odds ratio;  = regression coefficient; CI = confidence interval; n=number of positive 
slides; N=total number of slides read 
aValues are adjusted for age and log transformed individual asexual parasite density  
bReference group   
cGeometric mean of positive samples 
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Discussion 
This study shows the parasitological characteristics in a rural area in Burkina Faso during 
distinct seasons. An important finding is that season appears to be a factor independent of 
age and asexual parasite density that drives gametocyte prevalence and density. The 
prevalence and density of asexual parasites and gametocytes increase during the wet 
season. Malaria transmission varies between villages but is intense in the entire study area. 
Estimated sporozoite rates are in line with results from previous studies performed in the 
same area7 as such studies described higher prevalences of infected mosquitoes reaching 20 
% during peak transmission period.  
Seasonal patterns of P. falciparum gametocyte prevalence have been described 
before4,5,11-13. Gametocyte prevalence at the start and peak of the wet season is higher than 
in the dry season. In addition, gametocyte density is also elevated in the wet season, 
although only at the peak and end of the wet season. The elevated gametocyte prevalence 
and density in the wet season generally coincides with an increased asexual parasite 
density.  
Gametocytes are derived from asexual parasites and asexual parasite density is strongly 
associated with gametocyte prevalence and density14-16. It is therefore not surprising that a 
strong correlation is found between asexual parasite density and gametocyte prevalence. 
The same argumentation may explain the negative association between gametocyte 
prevalence and age5,14,15. In addition, increased gametocyte density may be the result of a 
partial loss of immunity against gametocytes during the long dry season6, although evidence 
for the existence of specific gametocyte immunity remains inconclusive17.  
 Though gametocyte prevalence is found higher in younger children, the contribution of 
older children and adults to the infectious reservoir should be taken into consideration as 
they represent a big part of the whole population and contribute considerably to malaria 
transmission18-21. 
Our findings suggest that gametocyte prevalence and density may have an independent 
relationship with season. This follows from our finding that the effect of season on 
gametocyte prevalence and -to a lesser extent- density remains apparent after adjustment 
for age and asexual parasite density at the individual level. The development of 
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gametocytes from asexual parasites takes 8-11 days22, and variation in asexual parasite 
carriage in the weeks prior to the start of the wet season may (partly) explain the observed 
effect on gametocyte prevalence.  
Secondly, the elevated gametocyte prevalence that precedes the rise in sporozoite exposure 
and asexual parasite density may due to a sudden increase in uninfected mosquito bites in 
this period, as suggested by Paul and collaborators23. Parasites would indeed have a 
substantial fitness advantage if gametocytogenesis would be upregulated by uninfected 
mosquito bites. Our study design did not allow us to directly determine the relation 
between uninfected mosquito bites and gametocytogenesis since mosquito catches were 
not conducted throughout the dry season. The hypothesis, which gives equivocal results in 
rodent malaria studies24,25 require  future field studies with a longitudinal design26 in 
combination with more sensitive molecular detection  of gametocytes16,27.  
Studies using highly sensitive molecular methods have recently revealed that the vast 
majority of gametocytes remain undetected by microscopy16,27. Therefore our microscopical 
data only reflect the patterns of the relatively higher gametocyte densities, starting to 
increase at the beginning of the transmission season and continuing during the remainder of 
the wet season. The increased infection rate during the wet season may be the result of a 
higher complexity of infections, which may lead to an increased gametocyte production 
because of interclonal competition28. Extended duration of illness29 and/or the use of anti-
malarial drugs30 may further stimulate gametocyte carriage during the wet season. Finally, 
more efficient asexual parasite immunity halfway acquired through the wet season because 
of accumulated recent parasite exposure may also drive parasites towards sexual stage 
development6,11.  
In conclusion, linked parasitological and entomological data from an area of highly seasonal 
transmission in Burkina Faso, shows that microscopic gametocyte prevalence and density is 
independently determined by age, asexual parasite density and season. The mechanisms 
behind the seasonal component remain elusive and will be subject to further studies.  
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Summary 
Sexual stages of Plasmodium falciparum play a key role in the transmission of 
malaria. Studies on gametocytes are generally based on microscopical detection but more 
sensitive detection methods for P. falciparum gametocytes frequently detect sub-patent 
gametocytes. We have used Pfs25 mRNA QT-NASBA to quantify gametocytes in 412 samples 
from a cross-sectional study in Burkina Faso, covering all age groups, to determine age-
related patterns in gametocyte carriage and gametocyte density. The more sensitive QT-
NASBA technique gave estimates of gametocyte prevalence 3.3 fold higher than microscopy 
(70.1% versus 21.4% respectively). Prevalence of gametocytes significantly decreased with 
age. Our data suggest that asexual parasite densities are primarily responsible for the age-
related decrease of gametocyte prevalence, possibly due to developing asexual stage 
immunity. Gametocyte densities decrease also with age, primarily due to decreasing asexual 
parasite densities; only a small but significant age effect on gametocyte density may be due 
to developing sexual stage-specific immunity.  
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Introduction 
 Malaria is caused by protozoan parasites of the genus Plasmodium. The life cycle of 
these parasites consists of both asexual and sexual phases occurring in two hosts. Sexual 
reproduction occurs in the invertebrate vector, Anopheles mosquitoes for human malaria, 
while reproduction in the vertebrate host is solely asexual. However, sexual stage 
development starts in the vertebrate host where a proportion of the asexual parasites 
transform into sexual stages, called gametocytes. The gametocytes can infect mosquitoes, 
reproduce sexually and are responsible for ongoing transmission of malaria to the next host. 
Despite the importance of gametocytes for the spread of malaria, relatively little is known 
about sexual stage development in comparison to the asexual stages that cause disease 
symptoms. Until recently, studies on gametocytes were based on microscopy, which is 
rather insensitive and inaccurate in quantification of gametocytes in blood samples 
(Ouédraogo AL and others, unpublished data). Individuals without microscopically 
detectable gametocytes can infect mosquitoes1 and higher gametocyte prevalences are 
found when larger volumes of blood are used for analysis.2--4 More sensitive detection 
methods for Plasmodium falciparum gametocytes such as the Pfs25 or Pfg377 reverse 
transcriptase polymerase chain reaction5,6,7 are able to detect sub-patent gametocytes,8,9 
which can be quantified by Pfs25 mRNA QT-NASBA.10,11 The Pfs25 QT-NASBA has a detection 
limit of 20-100 gametocytes per ml of blood and the high throughput format allows its use 
in large epidemiological studies. A previous study with Pfs25 QT-NASBA showed very high 
prevalence of gametocytes in symptomatic children in Kenya.11  
 The objective of this study is to determine submicroscopic levels of gametocytes in a 
different epidemiological setting. We have used Pfs25 QT-NASBA to quantify gametocytes in 
412 samples from a cross-sectional study in Burkina Faso, covering all age groups and 
determined age-related patterns in gametocyte carriage and density.  
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Materials and Methods 
 Field study. The study took place in 6 small rural villages 30 kilometers north of 
Ouagadougou, Burkina Faso. These villages are situated in a Sudanese savannah area with a 
marked wet season from June to October. The distance between villages varies from 1 to 5 
km. Malaria transmission is highest in the wet season and peaks around September.  
P. falciparum is responsible for 90% of malaria infections with Anopheles gambiae and A. 
funestus as major vectors.12 Health care facilities are equally distributed in the six villages 
and residents live by subsistence farming.  
A cross-sectional survey was carried out at the end of the transmission season (December 
2003) at which time 412 villagers of all ages were enrolled. Adults and children of both sexes 
and exclusively of the Mossi ethnic were randomly included in the study by order of arrival 
until a minimum number of 10 individuals per age group with informed consent were 
included. A finger prick blood sample was taken from all participants. Thick and thin blood 
films were made, air-dried and stained with 5% Giemsa. For collection of nucleic acids, 100 
l of blood was mixed with 900 l of L6 lysis buffer and stored for RNA extraction. Most 
participants were asymptomatic, only 7% had a body temperature of over 37.5 °C and were 
treated with chloroquine according to the national policy after blood samples for the study 
had been obtained. The study received ethical approval of the Ministry of Health of Burkina 
Faso. 
 Microscopic detection of P. falciparum parasites. Samples were considered negative 
if no parasites were detected in 100 fields (10x100 magnification). Both asexual stage and 
gametocyte densities were simultaneously assessed by counting against 500 leucocytes in 
the thick smear. The lower limit of microscopy for gametocyte quantification was therefore 
evaluated to 16 gametocytes/ l of blood. Parasite counts were converted to numbers of 
parasites per µl by assuming a standard count of 8000 leucocytes/µl of blood. Each sample 
was read independently by two microscopists. A third reader was involved when the 
difference between the readers exceeded 30% and in such a case the median reading was 
used (CNRFP Ouagadougou).  
 Real-time Pfs25 QT-NASBA and nucleic acid extraction. Nucleic acids were extracted 
from blood samples using the Guanidiumisothiocyanate (GuSCN)/silica procedure13 and 18S 
rRNA real-time QT-NASBA14 and Pfs25 real time mRNA QT-NASBA11 were performed as 
described elsewhere. Briefly, real-time QT-NASBA for Pfs25 mRNA (Genbank accession 
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number AF193769.1) was performed on a Nuclisens EasyQ analyser (bioMérieux) using the 
Nuclisens BasicKit for amplification according to manufacturer’s instructions at a KCl 
concentration of 80mM. Reactions were performed in a total reaction volume of 10 l per 
reaction. Forward primer: 5’-gactgtaaataaaccatgtggaga-3’; reverse primer: 5’-
aattctaatacgactcactatagggagaaggcatttaccgttaccacaagtta-3’; Pfs25 molecular beacon: 5’-
TexasRed-cgatcgcccgtttcatacgcttgtaacgatcg-DABSYL-3’. For quantification, time to positivity 
is calculated, i.e. the time point during amplification at which the fluorescence detecting 
target amplicons becomes higher than the mean fluorescence of three negative controls + 
20 standard deviations (SD). The use of a standard gametocytes stage V dilution series 
allows exact calculation of the number of gametocytes present in unknown samples.10,11 
  
Data analysis. Statistical analyses were performed in SPSS 12.0.1. Because parasitological 
parameters, including total parasite and gametocyte densities, were not different between 
the 6 villages (data not shown), samples were pooled for analyses. Spearman correlation 
was used to determine correlation between results of microscopy and QT-NASBA. A 
10Log(x+1) transformation was applied to both asexual parasite and gametocyte counts to 
allow negative samples in the analysis. Geometric mean of gametocyte density was 
calculated for gametocyte positive samples and for all samples, including the negatives. To 
determine the relation to age group and asexual parasite density, logistic regression was 
used for gametocyte prevalence and linear regression for gametocyte density. The age 
range was very large and therefore we have analyzed age group as a categorical variable in 
comparison to the oldest age group of 25+ years (adults). With such analyses, a decrease of 
the correlation coefficient with increasing age group indicates a negative relation between 
age group and the parameter under investigation. 
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Results 
 Comparison QT-NASBA and microscopy for gametocyte detection. Blood samples for 
QT-NASBA analysis were collected randomly from 412 individuals with mean age of 17.5 yrs 
(range 2--83 years) after informed consent. All participants were assigned to age groups <5 
years (n = 79), 5--9 years (n = 97), 10--14 years (n = 78), 15--24 years (n = 71) and ≥ 25 years 
(n = 87). 
 Pfs25 mRNA QT-NASBA confirmed 92% (81/88) of samples gametocyte positive by 
microscopy with a geometric mean QT-NASBA gametocyte density of 3.90*103 per ml blood 
(IQR 5.11*102--2.72*104). In general, gametocyte densities detected by microscopy were 
close to the microscopical detection limit with 1 gametocyte /500 leucocytes counted in 
51.1% of these samples. The more sensitive QT-NASBA detected gametocytes in an 
additional 208 samples with a geometric mean density below the detection limit of 
microscopy (1.98*103 per ml blood; IQR 3.95*102--9.60*103).  
 Parasite prevalence. Detection of gametocytes by Pfs25 real-time QT-NASBA 
considerably increased gametocyte prevalence from 21.4% (microscopy) to 70.1%. Total 
parasite and gametocyte prevalence as detected by the two methods are shown for all age 
groups in figure 1. The detection of total parasite prevalence and gametocyte prevalence 
were higher by QT-NASBA compared to standard microscopy. A decrease of P. falciparum 
prevalence with age was found by microscopy but not by QT-NASBA, indicating that parasite 
densities in adults were merely reduced to submicroscopic levels. Gametocyte prevalence 
was negatively associated with age and 3.2--3.8 fold higher in the 3 youngest age groups (0--
15 years) compared to that in adults (25+ years) by QT-NASBA analyses (table 1A). For 
microscopy this was 1.7--1.9 fold higher (data not shown). 
 Asexual parasite densities detected by microscopy decrease significantly with age 
(Ouédraogo and others, unpublished data). Because gametocytes are derived from their 
asexual progenitors, it is important to separately detect the effects of age on asexual 
parasites and on gametocytes. Therefore, the asexual parasite density was included as an 
explanatory variable in the analyses of age-related decrease of gametocyte prevalence. 
After adjustment for asexual parasite density, no significant decrease of gametocyte 
prevalence, detected by either QT-NASBA (table1A) or microscopy (data not shown) was 
found with increasing age.  
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A 
 
B 
 
Figure 1: Parasite prevalence for the different age groups, calculated by QT-NASBA (A) and 
microscopy (B). Solid bars represent total parasite prevalence, including asexual parasites and 
gametocytes. Open bars represent gametocyte prevalence.  
 
 A significant positive association was shown between asexual parasite density and 
gametocyte prevalence (OR = 1.27; 95% CI = 1.16--1.38; p<0.001 for QT-NASBA (table 1A); 
OR = 1.12; 95% CI = 1.01--1.25; p = 0.040 for microscopy). These data suggest that the age-
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related decrease of gametocyte prevalence is probably the result of decreasing asexual 
parasite densities. 
 Parasite density. Figure 2 shows that gametocyte densities as well as the asexual 
parasite densities decrease with age. Linear regression analyses showed a significant 
negative effect of age on gametocyte density detected by both QT-NASBA (Table1B) and 
microscopy (data not shown). Individuals over 15 years of age carried lower gametocyte 
densities than children aged 0--15 years.  
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Figure 2: Mean parasite densities for different age groups, calculated for all samples. Solid 
bars represent asexual parasite density measured by microscopy. Striped bars represent 
gametocyte density measured by QT-NASBA. Numbers of individuals per group are presented on top 
of bars. Error bars indicate standard deviations. 
When asexual parasite density was included as a covariate, a significant positive relation 
was found with gametocyte density by both QT-NASBA (  = 0.18; se ( ) = 0.033; p<0.001 
(table 1B) and microscopy (  = 0.076; se ( ) = 0.036; p = 0.036).  
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Table1: Effect of asexual parasite density on age distribution of gametocyte carriage and 
gametocyte density measured by QT-NASBA  
A. Gametocyte prevalence  
Age group  N OR a (95% CI)  P-value  OR b (95% CI)  P-value 
 <5 79 3.16 (1.61-6.20)  0.001  1.53 (0.73-3.24)  0.262 
 5-9 97 3.83 (2.00-7.37)  0.000  1.86 (0.90-3.83)  0.094 
              10-14     78          3.35 (1.69-6.63)               0.001                  1.85 (0.89-3.88)                0.101 
 15-24 71 1.52 (0.80-2.88)                0.197  1.05 (0.53-2.08)  0.884 
 25 87 1.0c     1.0 c  
B. Gametocyte density d  
Age group  N β a (se (β))  P-value  β b (se(β))  P-value 
 <5 79 1.11 (0.26)  0.000  0.50 (0.28)  0.071 
 5-9 97 1.19 (0.25)  0.000  0.59 (0.27)  0.027 
 10-14 78 1.02 (0.27)  0.000  0.53 (0.27)  0.053 
 15-24 71 0.45 (0.27)  0.098  0.16 (0.27)  0.556 
 25 87 0.0 c     0.0 c 
C. Gametocyte density e, f 
Age group  N β a (se (β))  P-value   
 <5 61 0.406 (0.19)  0.037  
 5-9 78 0.369 (0.19)  0.046 
 10-14 61 0.248 (0.19)  0.201 
 15-24 44 0.213 (0.21)  0.309 
 25 45 0.0 c 
a Crude values of odds ratio (OR) and β; b OR and β adjusted for 10Log asexual parasite density. 
Asexual density OR = 1.27 (CI = 1.16--1.38, p<0.001) for gametocyte prevalence and β = 0.18 (se(β) = 
0.03; p<0.001) for gametocyte density; CI confidence interval; se standard error; c age group 25 
years was used as reference group; d All samples; e Samples from Pfs25 QT-NASBA positive 
gametocyte carriers; f Adjustment for asexual density was not significant with β = 0.023, se (β) = 
0.026 and p = 0.378. 
 
After this adjustment for asexual parasite density, the age-related difference in gametocyte 
density has mostly disappeared although a trend remained. These results suggest that age-
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related decrease of gametocyte densities mainly depend on asexual density as shown for 
gametocyte prevalence.  
Calculations of mean gametocyte densities are influenced by gametocyte prevalence 
if gametocyte-negative samples are included. Therefore, any factor that influences 
gametocyte prevalence may have been included in the analysis, without necessarily having a 
direct relation to gametocyte density. To avoid the risk of incorporating such indirect 
effects, the analyses were repeated in only QT-NASBA gametocyte-positive samples. Asexual 
density still tended to decrease with age, although the relation was not significant (p = 
0.378). However, QT-NASBA gametocyte densities still decreased slightly with age. Table 1C 
shows that the 2 youngest age groups (<10 years) carry significantly higher gametocyte 
densities compared to adults. This effect of age is independent of asexual density. Such an 
age effect was not significant for microscopy, with or without asexual parasite density as a 
covariate.  
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Discussion 
 Pfs25 real-time QT-NASBA showed an overall gametocyte prevalence of 70.1% 
during a cross-sectional study at the end of the rainy season in Burkina Faso, which is higher 
than in studies based on microscopy15,16. Although the additionally detected gametocyte 
carriers in general have very low gametocyte densities, the potential contribution of this 
group to the infectious reservoir should not be ignored (Schneider and Bousema and others, 
unpublished data).11 Therefore, transmission studies based on mosquito feeds with random 
population samples16--18 will give a more adequate estimation of population-wide 
transmission potential than studies based on microscopy.15,19--21 
Age-related decreases in both asexual parasites and gametocytes have been shown 
before.15,16,18,22--24 Such relations may be the result of developing immunity to asexual and 
sexual stages of Plasmodium falciparum over time. In this study, the age-dependent 
decrease of asexual parasites suggests the development of asexual stage immunity. 
Gametocyte prevalence and densities also decreased with age. As these stages are formed 
from their asexual progenitors, this may be the result of a lower availability of asexual 
progenitors (asexual stage immunity), of cross-stage immunity25 or of sexual stage-specific 
immunity. Our results show that the relation between age and both gametocyte prevalence 
and density depends primarily on asexual parasite density, suggesting that asexual or cross-
stage immunity may be an important determinant. This effect may obscure direct influences 
of age, i.e. anti-gametocyte immunity. We have adjusted for this effect in two different 
ways. 1) By adjusting for asexual parasite density. Although a trend was seen, age-related 
decreases in gametocyte density were non-significant after this adjustment. However, as a 
result of adjustment with highly variable asexual parasite densities, larger samples sizes may 
be required to obtain significant relationships. 2) By selecting only Pfs25 QT-NASBA positive 
samples. The influence of asexual parasite density was reduced to insignificant levels in this 
selection, while an age-related decrease in gametocyte density was still seen. This decrease 
of gametocyte densities with age, unaffected by asexual parasite densities, may be the 
result of anti-gametocyte immunity. However, the age-related, decrease of gametocytes is 
likely determined by immunity that results in primarily a decreased asexual parasite density 
rather than direct effect on gametocytes. 
The influence of asexual parasite density on gametocytes, described above, was 
based on analyses including microscopically counted asexual parasites. Although 
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microscopical detection of asexual parasites is more robust than that of gametocytes, more 
sensitive methods like QT-NASBA may also detect sub-patent asexual parasites. Ideally we 
would have included asexual parasite density determined by QT-NASBA as a covariate. QT-
NASBA is currently available for quantification of the total parasite load14 or for gametocytes 
only, but not yet for specific quantification of asexual parasites as is the case for other 
molecular biology methods such as PCR7,14.  
 Our results were obtained with samples collected at the end of the wet season. With 
a marked seasonal transmission in Burkina Faso, we cannot generalize these results to all 
seasons. It is possible that gametocyte prevalence and mean gametocyte densities as well as 
the relations with age vary over time. However, in a preceding study over various seasons, 
of which the present samples are a small part, we came to similar conclusions with 
microscopical parasite detection (Ouédraogo and others, unpublished data). QT-NASBA 
analysis of samples of cross-sectional surveys in other seasons will be performed. 
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Summary  
Malaria transmission depends on the presence of gametocytes in the peripheral 
blood. In this study, the age-dependency of gametocytaemia was examined by microscopy 
and molecular tools.  
A total of 5,383 blood samples from individuals of all ages were collected over six cross 
sectional surveys in Burkina Faso. One cross-sectional study used quantitative nucleic acid 
sequence based amplification (QT-NASBA) for parasite quantification (n=412). The 
proportion of infections with concurrent gametocytaemia and median proportion of 
gametocytes among all parasites were calculated. 
Asexual parasite prevalence and gametocyte prevalence decreased with age. Gametocytes 
made up 1.8% of the total parasite population detected by microscopy in the youngest age 
group. This proportion gradually increased to 18.2% in adults (p<0.001). Similarly, 
gametocytes made up 0.2% of the total parasite population detected by QT-NASBA in the 
youngest age group, increasing to 5.7% in adults (p<0.001). This age pattern in 
gametocytaemia was also evident in the proportion of gametocyte positive slides without 
concomitant asexual parasites which increased from 13.4% (17/127) in children to 45.6% 
(52/114) in adults (OR 1.55, 95% CI 1.38-1.74, p<0.001).  
The findings of this study suggest that although gametocytes are most commonly detected 
in children, the proportion of asexual parasites that is committed to develop into 
gametocytes may increase with age. These findings underscore the importance of adults for 
the human infectious reservoir for malaria. 
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Introduction 
The malaria parasite’s life- cycle is composed of several developmental stages, one of which 
is the transmissible sexual stage comprising male and female gametocytes. Mature 
gametocytes are apparently benign, causing no overt disease symptoms. They appear to be 
developmentally arrested at the G0 phase of the cell cycle and circulate within erythrocytes 
in the peripheral blood of the human host until they are taken up by a feeding female 
mosquito. In the mosquito midgut, gametocyte activation and fertilization take place. The 
subsequent formation of sporogonic stages results in the development of thousands of 
sporozoites that migrate to and invade the salivary glands, rendering the mosquito 
infectious to humans.  
 
During the course of an infection with Plasmodium falciparum, gametocytes are generated 
from asexual stage parasites. Only a small fraction of the asexual parasites of P. falciparum 
commit to form gametocytes 1 and as a result only a fraction of infected individuals also 
harbour gametocytes 1,2. It is now understood that this apparently low occurrence of 
gametocytes is partly a reflection of the low sensitivity of microscopy for the detection of 
gametocytes 2,3. However, the fact remains that asexual parasitaemia is not always 
accompanied by gametocyte carriage 1-3, and that the relationship between asexual parasite 
density and gametocyte prevalence or density is not straightforward. Some studies report a 
positive association between asexual parasite densities and gametocyte prevalence 4-6 and 
density 4 while others observe inverse associations 7,8 or report that the association may be 
modified by age 2.  
 
Factors that trigger and regulate the commitment of asexual stage parasites to gametocytes 
are largely unknown but are thought to include intrinsic parasite factors 9, anti-malarial 
treatment 4,6,10  and treatment outcome 4-6,11 , fever 7,8, haematological disruptions 6,12,13 and 
the presence of competing parasite strains 14,15 or species 6,16. In general the mechanism of 
sexual commitment appears to be highly plastic and environment sensitive 17,18. The flexible 
gametocyte production can be interpreted as a response mechanism of the parasite to 
stressful situations: if the survival of the asexual stage parasite is challenged, the investment 
in transmission stages increases.  
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Here, we explore age-dependent variation in gametocytaemia in a series of cross-sectional 
surveys in an area of seasonal malaria transmission in Burkina Faso, using both microscopy 
and quantitative nucleic acid sequence based amplification (QT-NASBA).  
 
Methods 
Study site and population 
The study was carried out in the vicinity of Ouagadougou, the capital of Burkina Faso. The 
area has the ecological characteristics of Sudan savannah. Participating populations from six 
villages (longitude: 1° 46’- 1°79’; latitude: 12°52’-12°61’) were of the same ethnic group 
(Mossi) and had similar age distributions. Transmission intensity is intense and seasonal in 
this region. Study subjects were given detailed explanations of the procedures, risk and 
benefits involved in the study and their consent was obtained.  The study protocol was 
viewed and approved by the Ministry of Health of Burkina Faso (Research's Authorization 
number 2000/3174/MS/SG/DEP). 
 
Blood sample collection 
Cross-sectional surveys were performed in January, May, August and December 2002 and in 
April and December 2003. Participants were randomly selected from previously determined 
age groups (0.5–4, 5–9, 10–14, 15–24 and 25+ years) based on census lists and computer 
generated randomization tables. Thick and thin blood smears were made from finger-prick 
blood. The body temperature was measured and febrile individuals who were parasitaemic 
were treated with chloroquine according to the national policy in 2002. In the cross-
sectional survey of December 2003, a single finger prick sample was used for blood smears 
and the collection of nucleic acids for quantitative-nucleic acid sequence based 
amplification (QT-NASBA); 100µL blood samples were collected from 412 volunteers of all 
ages from the six villages. The first part of the RNA extraction was done in the field following 
the original guanidinium isothiocyanate (GuSCN) RNA extraction method 19 until the nucleic 
acids were bound to silica dioxide particles. At this point, samples were stored at -20°C and 
transferred to the laboratory for completion of the extraction and QT-NASBA analysis.  
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Microscopical detection of P. falciparum parasites  
Samples were considered negative if no parasites were detected in 100 high-power fields of 
Giemsa-stained thick blood smears. Both asexual stage and gametocyte densities were 
assessed in the thick smear by counting against 500 and 1,000 leucocytes, respectively. 
Based on this approach, the lower limit of microscopy for gametocyte quantification was 
estimated at 8 gametocytes/ l of blood. Parasite counts were converted to numbers of 
parasites per µl by assuming a standard count of 8,000 leucocytes/µl of blood. Each sample 
was read independently by two microscopists and the mean density was used. A third 
reader was involved when the first two readers disagreed about the prevalence of 
gametocytes or their estimated densities differed ≥30%. In these cases the mean density of 
the two closest readings was used.  
 
Real-time Pfs25 QT-NASBA and nucleic acid extraction 
18S rRNA real-time QT-NASBA and Pfs25 real time mRNA QT-NASBA were performed as 
described elsewhere 20. Briefly, real-time QT-NASBA for Pfs25 mRNA (Genbank accession 
number AF193769.1) was performed on a Nuclisens EasyQ analyser (bioMérieux) using the 
Nuclisens Basic Kit for amplification according to manufacturer’s instructions at a KCl 
concentration of 80mM. Reactions were performed in a total reaction volume of 10 l per 
reaction. For quantification, time to positivity is calculated, i.e. the time point during 
amplification at which the fluorescence detecting target amplicons becomes higher than the 
mean fluorescence of three negative controls + 20 standard deviations (SD). The use of a 
standard gametocyte stage V dilution series allows exact calculation of the number of 
gametocytes present in unknown samples 20. The sensitivity of this method is 20-100 
gametocytes/mL.  
 
Statistical analysis  
The age-dependency of gametocytaemia by microscopy was determined by categorizing the 
population into 0.5-2, 3-4, 5-9, 10-14, 15-19 and ≥20 year-old individuals 2. For QT-NASBA 
data, numbers were smaller and age groups were combined to form 0.5-4, 5-9, 10-19 and 
≥20 year-old individuals. The proportion of asexual stage parasite carriers that also 
harboured gametocytes was calculated. Similarly, the individual proportion of gametocytes 
among total parasites was calculated by dividing the individual gametocyte density by the 
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total parasite density (asexual parasite density plus gametocyte density). An identical 
approach was used for QT-NASBA where the Pfs25 QT-NASBA gametocyte prevalence or 
density was divided by the 18S QT-NASBA total parasite prevalence or density. Age-
dependent trends in parasite carriage were determined by linear (density after log 
transformation) or logistic (prevalence) regression models and regression coefficients or 
odds ratios are presented, respectively. Estimates were adjusted for seasonality (dry, start 
wet, peak wet and end wet) where appropriate. The majority of individuals were only 
included in one of the surveys. Several individuals were included in more than one cross-
sectional survey with a time-gap between repeated measures of two months (n=484) or ≥4 
months (n=781). Adjusting for the correlation between observations from the same 
individual by generalized estimating equations (GEE) did not indicate a significant impact of 
autocorrelation (i.e. estimates and confidence intervals remained unaltered) and, therefore, 
conventional regression models were used. Trends in other variables were determined by 
χ2-test for trend or non-parametric trend tests for continuous variables. All statistical 
analyses were performed using STATA 11 [Statacorp, Texas US].  
 
Results 
Overall, the six cross-sectional studies yielded a total of 5,383 observations: 1,216 
observations from January 2002, 968 from June, 749 from August, 599 from December, 
1,084 from April 2003 and 767 from December 2003. 58.1% of the participants were of the 
female gender (3,127/5,383). Details on the seasonality of parasite carriage were presented 
previously 21. These findings were derived from 3154 individuals, 59.9% (1889/3154) of 
whom were seen once, 21.7% (685/3154) twice, 10.1% (320/3154) three times, 5.1% 
(161/3154) four times, 2.4% (75/3154) five times and 0.8% (24/3154) six times. The vast 
majority of individuals who donated a blood sample were afebrile: Only 5.1% of children 
below 15 years of age had a temperature ≥37.5°C (165/3,250) and 1.0% of older individuals 
(21/2,105).   
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Figure 1. Parasite carriage in different age groups by microscopy. Asex = asexual parasite; 
gcyt = gametocyte. The number of asexual parasite carriers (with gametocytes) for the 
different age groups was 0.5-2y: 297 (127); 3-4y: 468 (171); 5-9y: 1053(326); 10-14y: 
690(174); 15-19y: 254(72); 20+y: 285(114).  
 
Figure 2. The prevalence and density of gametocytes relative to total parasite carriage by 
microscopy. The number of asexual parasite carriers (with gametocytes) for the different 
age groups was 0.5-2y: 297 (127); 3-4y: 468 (171); 5-9y: 1053(326); 10-14y: 690(174); 15-
19y: 254(72); 20+y: 285(114). Note: data for those carrying gametocytes in the absence of 
asexual parasitaemia were excluded (see Figure 3). 
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The prevalence of asexual parasites (OR 0.59; 95% CI 0.57-0.62, p<0.001) and gametocytes 
(OR 0.70; 95% CI 0.67-0.74, p<0.001) decreased with age (Figure 1).  In parasite positive 
individuals, the log-transformed density of asexual parasites also decreased over age 
categories ( =-0.23; 95% CI -0.24 – -0.21, p<0.001). The gametocyte density in gametocyte 
carriers also decreased significantly but to a lesser extent ( =-0.041; 95% CI -0.055 – -0.028, 
p<0.001). The proportion of infections with concomitant gametocytaemia decreased with 
age (Figure 2). Whilst 37.0% (110/297) of 0.5-2 year-old carriers of asexual stage parasites 
concurrently had gametocytes, this was only true for 12.8% (62/485) of the parasite carriers 
who were 20 years old and above (OR=0.76;95% CI 0.72-0.81, p<0.001). In contrast with this 
trend, the median proportion of gametocytes among all parasites increased with increasing 
age (Figure 2). Thus, whilst gametocytes only represented 1.8% of the density of  the total 
parasite population in the youngest age group, this proportion gradually increased to a peak 
of 18.2% in adults (β=0.42; 95% CI 0.33-0.51, p<0.001). Although the majority of gametocyte 
carriers also harboured asexual parasites, microscopical evidence of concurrent asexual 
parasitaemia was lacking in 17.8% (175/984) of all gametocyte carriers. The proportion of 
gametocyte carriers without concurrent asexual parasites detected by microscopy was 
13.4% (17/127) in children below two years of age and increased with age to 45.6% (52/114) 
in the oldest age group (Figure 3; trend for age in categories OR 1.55, 95% CI 1.38-1.74, 
p<0.001).  
 
Patterns of gametocyte carriage and asexual parasite carriage were unaffected by the 
presence of fever and did not change when molecular methods were used for parasite 
detection instead of microscopy. For the limited number of samples (n=412) for which both 
18S QT-NASBA (total parasite) and Pfs25 QT-NASBA (gametocyte) prevalence and density 
data were available, total parasite prevalence (OR =0.85; 95% CI 0.63-1.15, p=0.29) and 
gametocyte prevalence (OR=0.73; 95% CI 0.63-0.85, p<0.001) both decreased with 
increasing age (Figure 4). Log-transformed total parasite density showed a decrease with 
age ( =-0.36; 95% CI -0.44 – -0.28, p<0.001) that was more pronounced than that of 
gametocyte density ( =-0.096; 95% CI -0.17 – -0.017, p=0.02). Densities of gametocytes 
detected by Pfs25 QT-NASBA in gametocyte carriers were low with a median gametocyte 
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density of 2.3 gametocytes/ L (IQR 0.4-10). Similar to observations by microscopy, the 
proportion of parasite carriers with concurrent gametocytes decreased with age. While 
81.1% (60/74) of parasite carriers in the youngest age group harboured gametocytes, this 
proportion gradually decreased to 62.0% (67/108) in the oldest age group (OR=0.75;95% CI 
0.64-0.87, p<0.001). On the other hand, and again consistent with the pattern revealed by 
microscopy, the median proportion of gametocytes among total parasites increased from 
0.2% in the youngest to 5.7% in the oldest age group (β=0.61; 95% CI 0.35-0.86, p<0.001, 
Figure 5).  
  
Figure 3. Gametocyte carriage in the absence of microscopically detectable asexual 
parasites. Bars indicate the proportion of microscopically detected gametocyte carriers in 
each age category without microscopically confirmed asexual parasites. Error bars indicate 
the upper and lower limit of the 95% confidence interval around the proportion. The 
number of gametocyte carriers (without concurrent asexual parasitaemia) for the different 
age groups was 0.5-2y: 127(17); 2-3y: 171(17); 5-9y: 326(40); 10-15y 174(25); 15-20y: 
72(24); 20+y: 114(52).  
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Figure 4. Parasite carriage by quantitative nucleic acid based amplification (QT-NASBA) in 
different age groups. Total parasite prevalence and density were determined by 18S QT-
NASBA; gametocyte prevalence and density by Pfs25 QT-NASBA. The number of parasite 
carriers (with concurrent gametocytaemia) for the different age groups was 0.5-4y: 74(60); 
5-9y: 93(79); 10-19y: 117(83); 20+y 108(67).  
 
 
 Figure 5. The age-dependent prevalence and density of gametocytes relative to total 
parasite carriage by QT-NASBA. The number of parasite carriers (with concurrent 
gametocytaemia) for the different age groups was 0.5-4y: 74(60); 5-9y: 93(79); 10-19y: 
117(83); 20+y 108(67).  
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Discussion 
This study indicates that while the global prevalence of asexual parasites and 
gametocytes is highest in children, the density of gametocytes relative to the total parasite 
concentration increases with age. This age-dependent increase is apparent by microscopy 
and by a more sensitive molecular gametocyte detection technique. These findings suggest 
that the commitment of asexual malaria parasites to the sexual pathway may increase with 
age.  
P. falciparum sexual stage commitment is crucial for the transmission of parasites from man 
to mosquito and the subsequent spread of malaria in the human population. A better 
understanding of the factors that influence the switch from asexual to sexual stage 
development in the human host would therefore provide new opportunities for malaria 
control. In the study presented here, a large data set collected during cross sectional surveys 
in two consecutive years was analyzed to explore factors associated with gametocyte 
production. Numerous studies have shown that the prevalence of gametocytes decreases 
with age 4,5,22-28. The present study attempted to determine whether this is the simple 
consequence of an age-dependent decline in the prevalence and density of asexual 
parasites 4-6 or if there may be an age-dependent production of gametocytes. The 
proportion of gametocytes relative to total parasite density increased with age in the 
current study 2. Whilst gametocytes only comprised 1.8% of the total parasite population in 
the youngest children, they comprised 18.2% of the total parasite population in the oldest 
age-group. These calculations may have been affected by the limited sensitivity of 
microscopy for detecting low gametocyte densities 29 but the association between age and 
gametocyte production was supported by two additional lines of evidence. 
 In the analyses on the proportion of asexual parasite carriers with concurrent 
gametocytaemia and the proportion of gametocytes among the total parasite population, 
the group of individuals with microscopically detectable gametocytes but no asexual 
parasites was excluded. This group was expected to form a relatively small subset of 
individuals whose asexual parasites were recently cleared by immune responses or 
antimalarial drugs. Contrary to this expectation, the presence of gametocytes in the absence 
of asexual parasites detectable by microscopy was not rare: one in six gametocyte carriers 
had no microscopical evidence of asexual parasitaemia and this proportion increased with 
age. One theoretical explanation for this observation could be that a higher proportion of 
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infections were recently cleared by anti-malarial drugs in adults. After the clearance of 
asexual parasites by chloroquine, the most commonly used antimalarial drug in the study 
area, gametocytes may have persisted since these are largely unaffected by this drug 30.  No 
information on recent drug use was recorded in this study but it is unlikely that a difference 
in drug use between children and adults would explain the observations. Disease symptoms 
and anti-malarial drug use are more common in children, not in adults 31. A more likely 
explanation is that that low density (i.e. microscopically undetectable) malaria infections 
were more frequently accompanied by microscopically detectable gametocyte densities in 
older age-groups. This would support an age-dependent increase in commitment to 
gametocyte production. 
 
A last line of evidence comes from the molecular gametocyte detection tool that is at least 
100-fold more sensitive for detection of gametocytes 32. QT-NASBA detects gametocytes at 
densities as low as 0.02 gametocytes/µL 2,20. Similar to microscopical findings, the 
proportion of gametocytes relative to total parasite density detectable by QT-NASBA 
increased with age: from 0.2% in the youngest age group to 5.7% in the oldest individuals. 
These three lines of evidence suggest that the relative density of gametocytes increases 
with age in an area where transmission is intense and adults have developed an efficient 
anti-disease and anti-parasite immune response 33,34.  
The biological mechanism behind an age-dependent increase in sexual stage commitment is 
impossible to deduce from epidemiological data. It could plausibly result from 
epidemiological differences in infections between age-groups or from a response of the 
parasite to age-acquired immune responses and the resulting lower density of asexual 
parasites. The latter would suggest a strategic advantage for parasites that may increase 
gametocytaemia in response to conditions that negatively affect asexual stage parasite 
multiplication 35. The developmental decision to enter gametocytogenesis for P. falciparum 
occurs during the formation of the asexual schizont, which can commit its entire progeny of 
merozoites either to develop once more asexually, or to enter sexual differentiation 36. This 
decision may depend on the immune stress experienced by the parasites. 
Gametocytogenesis in Plasmodium chabaudi is increased in immunized compared to naïve 
mice 37. Similar findings for P. falciparum have been reported when parasites were exposed 
to immune stimuli in vitro 38. The findings from the current study suggest a similar 
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mechanism in natural infections where gametocytaemia increases in response to age-
acquired immune responses, decreasing asexual parasite densities or other age-dependent 
factors. Anaemia and drug treatment, likely triggers of gametocyte production 6,12,13 were 
not directly measured but are likely to be more common in children than adults and can 
therefore not explain the findings of a higher relative gametocyte density in adults. It is also 
possible that the association is explained by a longer duration of malaria infections in adults. 
Children are more likely to develop symptoms and seek treatment or benefit from a 
prophylactic effect of presumptive treatment 39. Infections may have a longer average 
duration in immune adults, giving parasites more time to develop gametocytes. The half-life 
of gametocytes is 3-6 days 40,41 and the density of gametocytes could therefore increase 
cumulatively when gametocytes have been produced for a longer period of time while 
asexual parasite densities are decreasing prior to sampling. Such an effect cannot be ruled 
out in this study although the asymptomatic nature of the vast majority of infections makes 
it plausible that most individuals harboured parasites for a sufficiently long time to develop 
gametocytes 41. It is also possible that gametocyte mortality is increased in children due to 
the high asexual parasite density-mediated release of cytokines 42,43, resulting in a lower 
relative gametocyte density. Gametocyte-clearing immune responses 44 may also have 
contributed to these observations but there is currently insufficient evidence for the 
functional relevance of such responses in malaria endemic countries or its age-dependency.  
 
In conclusion, the findings reported in this study suggest that once asexual population 
growth has been controlled by the host, the transmission benefits of increased gametocyte 
densities become apparent. These findings require confirmation in longitudinal studies that 
should ideally use molecular parasite detection tools. Although the patterns observed by 
QT-NASBA were similar to those by microscopy, the former is preferable since it detects 
gametocytes over a much wider range of densities 20. An additional advantage of molecular 
detection tools is that they would also allow the detection of sexual stage committed 
asexual parasites 45, which could provide an additional level of detail in studying the 
dynamics of gametocyte production. These findings have an important implication for 
malaria control: although the prevalence of asexual parasite and gametocyte carriage 
decreases with increasing age, adults can be important contributors to the human infectious 
reservoir. Adults constitute the majority of populations in malaria endemic areas and many 
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adults harbour (low densities of gametocytes. The current study suggests that the 
commitment to gametocytaemia may increase in adults, increasing their relative 
importance for the human infectious reservoir. Adults should therefore be taken into 
consideration when implementing interventions that aim at reducing malaria transmission. 
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Summary 
Man to mosquito transmission of malaria depends on the presence of the sexual 
stage parasites, gametocytes, that often circulate at low densities. Gametocyte densities 
below the microscopical threshold of detection may be sufficient to infect mosquitoes but 
the importance of submicroscopical gametocyte carriage in different transmission settings is 
unknown. 
Membrane feeding experiments were carried out on 80 children below 14 years of age at 
the end of the wet season in an area of seasonal malaria transmission in Burkina Faso. 
Gametocytes were quantified by microscopy and by Pfs25-based quantitative nucleic acid 
sequence-based amplification assay (QT-NASBA). The childrens’ infectiousness was 
determined by membrane feeding experiments in which a venous blood sample was offered 
to locally reared Anopheles mosquitoes. Gametocytes were detected in 30.0% (24/80) of the 
children by microscopy compared to 91.6% (65/71) by QT-NASBA (p<0.001). We observed a 
strong association between QT-NASBA gametocyte density and infection rates (p=0.007). 
Children with microscopically detectable gametocytes were more likely to be infectious 
(68.2% compared to 31.7% of carriers of submicroscopical gametocytes, p=0.001), and on 
average infected more mosquitoes (13.2% compared to 2.3%, p<0.001). However, because 
of the high prevalence of submicroscopical gametocyte carriage in the study population, 
carriers of sub-microscopical gametocytes were responsible for 24.2% of the malaria 
transmission in this population. Submicroscopical gametocyte carriage is common in an area 
of seasonal transmission in Burkina Faso and contributes substantially to the human 
infectious reservoir. Submicroscopical gametocyte carriage should therefore be considered 
when implementing interventions that aim to reduce malaria transmission.   
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Introduction 
The transmission of malaria depends on the presence of mature sexual stage 
parasites, gametocytes, in the human peripheral blood. Once ingested by a mosquito taking 
a blood meal, gametocytes develop through different mosquito-specific stages and 
ultimately result in infection of the mosquito salivary glands with sporozoites. This renders 
the mosquito infectious to humans. There is growing awareness that targeting gametocytes, 
either alone or as part of integrated control programmes, is essential for malaria control and 
elimination efforts 1-4. The identification of the human infectious reservoir is therefore 
important for successful malaria control. Gametocytes frequently occur at low densities, 
making microscopical detection complicated5. In the last decade, molecular tools have 
become available to detect and quantify gametocytes at densities well below the 
microscopical threshold, in the order of 0.02-10 gametocytes/µL of blood4. Using these 
techniques, it has become evident that the proportion of gametocyte carriers in the 
population has been grossly underestimated and that the gametocyte reservoir may be 2-5 
fold larger than assumed based on microscopy 6,7. Carriers of gametocytes at 
submicroscopical levels are capable of infecting mosquitoes 7-19 although at a lower degree 
than those with gametocytes detectable microscopically in whom gametocytes are present 
at higher densities 12,18. 
The importance of submicroscopical gametocyte carriage for malaria epidemiology and 
malaria control is the subject of some debate. While carriers of gametocytes at 
submicroscopical densities were concluded to be as important for the human infectious 
reservoir as carriers of microscopically-detectable gametocytes in areas of perennial 
transmission in Kenya 18 and Thailand16, data from the Gambia suggest that 
submicroscopical gametocyte carriers only form a very small fraction of the infectious 
reservoir in this area of seasonal transmission 20. This suggests that the relevance of 
submicroscopical gametocyte carriage may depend on transmission settings. 
 
Here, we determine the contribution of submicroscopical densities of gametocytes to the 
human infectious reservoir in an area of seasonal malaria transmission in Burkina Faso.  
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Methods 
This study was conducted in September-November 2005 in the village of Laye, 30km 
northwest of Ouagadougou, Burkina Faso. The area is characterised by Sudanese savannah 
with a marked wet season from June to October and an estimated entomological 
inoculation rate of 300-500 infective bites per person per year21. Asexual parasite carriage in 
the population shows seasonal fluctuations and was recently estimated at 60-90% in 
children below 15 years of age and 20-50% in adults22. Clearance was received by the 
Ministry of Health of Burkina Faso. Children below 14 years of age were randomly selected 
from village census lists and written informed consent was obtained from parents/guardians 
after the purpose of the study was explained.  Children were accompanied to the Centre 
National de Recherche et de Formation sur le Paludisme (CNRFP) 1 to 2 days after the 
consenting procedure. At CNRFP, children underwent a clinical examination and their 
axillary temperature was measured. Children were enrolled in membrane feeding 
experiments regardless of symptoms or the presence of asexual malaria parasites or 
gametocytes. Venous blood samples (3mL) were drawn into heparin-containing tubes for 
membrane feeding and for gametocyte detection both by microscopy and by real-time 
Pfs25 quantitative nucleic acid sequence based amplification (QT-NASBA). For all 
membrane-feeding assays, 3mL venous blood samples were obtained and fed to ∼50 locally 
colony-reared 4-5-day-old female A. gambiae sensu stricto mosquitoes. The mosquito 
colony was established three years prior to the current experiments. Blood was offered via 
an artificial membrane attached to a water-jacketed glass feeder maintained at 37°C. After 
10–15 min, fully fed mosquitoes were selected and kept on glucose at 29°C7. Unfed and 
partially fed mosquitoes were removed by aspiration and discarded. Mosquito midguts were 
examined after 7 days for the presence of oocysts following dissection in 2% 
mercurochrome. A second microscopist confirmed the presence of oocysts in midguts that 
were scored positive. 
Only the total number of oocysts per batch of fed mosquitoes was recorded; not the 
number of oocysts per individual mosquito.Experiments in which a minimum of 10 
mosquitoes were examined on day 7 after feeding were included in the analyses. After 
membrane feedings, children with fever (axillary temperature ≥ 37.5°C) and malaria 
parasites were treated with artemisinin-based combination therapy according to the 
national guidelines. Individuals for whom infections other than malaria were suspected 
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were accompanied to the nearest health facility for appropriate clinical care. The study 
protocol was viewed and approved by the Ministry of Health of Burkina Faso on August 8th 
2000(Research's Authorization number 2000/3174/MS/SG/DEP). 
 
Microscopical detection of P. falciparum parasites.  
Samples were considered negative if no parasites were detected in 100 fields. Both asexual 
stage and gametocyte densities were simultaneously assessed by counting against 1000 
leucocytes in the thick smear. The lower limit of microscopy for gametocyte quantification 
was therefore estimated at 8 gametocytes/ l of blood. Parasite counts were converted to 
numbers of parasites per µl by assuming a standard count of 8000 leucocytes/µl of blood. 
Each sample was read independently by two microscopists and the mean density was used. 
A third reader was involved when the first two readers disagreed about the prevalence of 
gametocytes or their estimated densities differed ≥30%. In these cases the mean density of 
the two closest readings was used.  
 
Gametocyte detection by real time Pfs25 QT-NASBA 
Gametocyte  detection by Pfs25 QT-NASBA was performed as described elsewhere using a 
NucliSens EasyQ analyser (Bio-Mérieux) [23,24]. Nucleic acid was extracted from 50-µL 
blood samples as described by Boom et al.25. The first part of the RNA extraction was done 
in the field following the original guanidinium isothiocyanate (GuSCN) RNA extraction 
method25 until the nucleic acids were bound to silica dioxide particles. At this point, samples 
were stored at -20°C and transferred to the laboratory for completion of the extraction and 
QT-NASBA analysis. The number of gametocytes was calculated in relation to a standard 
gametocyte stage V dilution series [26], using the time point of amplification at which the 
fluorescence detecting target amplicons exceeded the mean fluorescence of three negative 
controls + 20 standard deviations. The Pfs25 QT-NASBA technique is gametocyte specific 
and has a detection limit of 20–100 gametocytes/mL24. Samples with Pfs25 QT-NASBA 
gametocyte concentrations <20 gametocytes/mL were considered gametocyte negative.  
 
Sample size considerations 
Based on a previous study in the area, we expected a gametocyte prevalence of 10-20% by 
microscopy and 70-80% by Pfs25 QT-NASBA [23]. Including 80 individuals in the membrane 
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feed experiments would allow us to detect a threefold lower infectiousness of 
submicroscopical carriers compared to microscopical gametocyte carriers12,20 when we 
assumed that 60% of the microscopical gametocyte carriers infected at least one mosquito18 
(Z =1.645; Z =0.84).  
 
Data analysis 
Data analyses were performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA) and Stata 
10 (Statacorp, Texas US). Densities of gametocytes were analysed on a log10-scale. The 
prevalence of mosquito infection (i.e. whether an individual infected at least one mosquito) 
and the proportion of infected mosquitoes were used as outcomes of the membrane 
feeding experiments and were related to Pfs25 QT-NASBA gametocyte density, age and 
fever in logistic and linear regression models. Individual oocyst densities in mosquitoes were 
not recorded.  
Chapter 5 
78 
 
Results 
We enrolled 80 children in our study who were aged 2.9 – 13.6 years. In line with previous 
studies from the study area, microscopy indicated an asexual parasite prevalence of 82.5% 
(66/80) and a gametocyte prevalence of 30.0% (24/80; Table 1)22,23.  
 
Table 1. Baseline characteristics  
 
Age, median (IQR) 6.2 (4.8 – 9.5) 
Sex, % male (n/N) 55.0 (44/80) 
Fever, %  (n/N)* 22.5 (18/80) 
Asexual parasite prevalence, % (n/N) 82.5 (66/80) 
Asexual parasite density/µL, median (IQR)¥ 1028.5  (585 – 
3662) 
Symptomatic malaria¶ 15.0 (12/80) 
Microscopic gametocyte prevalence, % (n/N) 30.0 (24/80) 
Microscopic gametocyte density/µL, median 
(IQR)¥ 
40.0 (16 – 45) 
QT-NASBA gametocyte prevalence, % (n/N)† 91.6 (65/71) 
QT-NASBA gametocyte density/µL, median 
(IQR) 
7.9 (1.4 – 48.9) 
*Fever=temperature ≥37.5°C; ¥for carriers only; ¶defined as fever with a parasite density ≥500 
parasites/µL; †only gametocyte densities ≥20 gametocytes/mL were considered Pfs25 QT-NASBA 
positive 
 
 
When the Pfs25 QT-NASBA was used for gametocyte detection, 91.6% (65/71) individuals 
were shown to be carrying gametocytes. There was a strong correlation between 
gametocyte densities detected by QT-NASBA and microscopy for microscopically 
gametocyte positive samples (Spearman correlation coefficient = 0.60; p=0.004). For nine 
individuals RNA collection failed, i.e. no sample was collected, and therefore no QT-NASBA 
data were available.  Membrane feeds were successful for all 80 individuals but, due to 
mosquito mortality between the day of feeding and the day of dissection, only a total of 74 
membrane feeds had at least 10 mosquitoes dissected and were therefore included in the 
analyses. The proportion of infected mosquitoes was positively associated with Pfs25 QT-
NASBA gametocyte density (Spearman correlation coefficient=0.34, p=0.007; Figure 1) and 
was not influenced by a clinical malaria episode (i.e. fever with a parasite density ≥500 
parasites/µL) (p=0.18) or the presence of fever (p=0.63).The relation between the 
proportion of infected mosquitoes and Pfs25 QT-NASBA gametocyte density was best 
described by the equation Y = 0.0176Ln(X) + 0.0187 (R2 = 0.153). 
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Figure 1. The relationship between Pfs25 QT-NASBA gametocyte density and the 
proportion of infected mosquitoes in membrane feeding experiments.  
The solid line indicates the best fitted line (Y = 0.0176Ln(X) + 0.0187; R2 = 0.153). The dashed 
line indicates the estimated microscopic threshold for gametocyte detection, 8 
gametocytes/µL, when screening 100 high power fields (i.e. ~1000 white blood cells). 
 
Of those children with microscopically detectable gametocytes, 68.2% (15/22) infected at 
least one mosquito compared to 31.7% (13/41) of children with submicroscopical 
gametocyte densities (p=0.001; Table 2).  
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Table 2. Membrane feeding results  
 
 Gametocyte 
carriage 
    
 Microscopy –   Microscopy –   Microscopy +   Total p-value 
 QT-NASBA – QT-NASBA + QT-NASBA +   
Prevalence in the 
population, % (n) 
6.9 (5) 60.3 (44) 32.9 (24) 100 (73)  
Density at 
feeding, median 
(IQR)* 
N.D. 7.5 (1.5 – 27.9) 33.8 (2.9 – 120.2) 8.2 (1.6 – 
49.7) 
0.13 
Proportion of 
infectious 
individuals, % 
(n/N) 
0.0 (0/5) 31.7 (13/41) 68.2 (15/22) 41.1 
(28/68) 
0.001¶ 
Proportion of 
infected 
mosquitoes, % 
(n/N) 
0.0 (0/151) 2.3 (28/1202) 13.2 (90/683) 5.8 
(118/2036) 
<0.001¶ 
Total number of 
oocysts/infected 
mosquitoes¥ 
0/0 36/28 250/90 286/118  
Relative 
contribution to 
transmission 
0% 24.2% 75.8% 100.0%  
* by Pfs25 QT-NASBA; ¶p-value for a test for trend; ¥only the total number of oocysts per batch of fed 
mosquitoes was recorded, not the number of oocysts of individual mosquitoes. Therefore only a 
summary measure can be presented and no analyses could be done on individual oocyst densities. 
The total number of samples is lower than 80 because QT-NASBA results were not available for 9 
individuals. Two individuals without QT-NASBA results that were gametocyte positive by microscopy 
were included.  The relative contribution to transmission was based on the product of the proportion 
of infected mosquitoes (4th row) and the prevalence of this subgroup in the population (1st row).  
 
The proportion of infected mosquitoes was also higher in carriers of microscopically- 
compared to submicroscopically-detectable gametocytes (p<0.001). Oocyst densities of 
individual mosquitoes were not recorded, only the total number of oocysts observed in each 
experiment. Formal statistical testing on oocyst burden could therefore not be done 
although the total number of oocysts relative to the number of infected mosquitoes was 
higher for individuals with microscopically-detectable densities of gametocytes. The relative 
contribution to transmission of microscopical and submicroscopical gametocyte carriage 
was determined based on their prevalence in the studied population and the proportion of 
mosquitoes infected by each group. This resulted in a relative contribution to malaria 
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transmission of 24.2% for submicroscopical gametocyte carriage, compared to 75.8% for 
microscopical gametocyte carriage. 
 
Discussion 
In this study, we observed that submicroscopical gametocyte carriage is common in 
children in an area of seasonal malaria in Burkina Faso. Although, on average, carriers of 
gametocytes at submicroscopical densities infected significantly fewer mosquitoes that 
themselves developed lower oocyst burdens, the contribution to the infectious reservoir of 
this age group was considerable and estimated at 24%. 
 
There are numerous reports that suggest that some individuals can infect mosquitoes 
despite the absence of microscopically detectable gametocytes7,8,10,12,16,18,19. However, it is 
unclear (i) how important this phenomenon is in areas of seasonal malaria20 and (ii) how 
important submicroscopical gametocyte densities are for malaria transmission in the 
general, typically asymptomatic, population. Several detailed studies on the infectiousness 
of carriers of submicroscopical gametocytes have been carried out, but only after 
chemotherapeutic treatment of symptomatic malaria cases7,18,20. Because children in those 
studies all had high densities of asexual parasites in the weeks prior to the mosquito feeding 
experiments, they were more likely to have gametocytes at the time of the membrane 
feedings5. Although it was previously shown that gametocyte carriage may be common in 
asymptomatic individuals as well27, findings from clinical trials cannot be extrapolated to the 
general population. To the best of our knowledge, the infectious reservoir has never been 
determined in the general population by means of the combination of molecular 
gametocyte detection tools with membrane feeding experiments used in the study 
described here. Although our experiments were restricted to children, our findings provide 
valuable information about the infectiousness of a cross-section of the population living in 
an area of seasonal malaria transmission. At the end of the wet season, 90% of the children 
in our study area carried gametocytes23, two-thirds of them at densities below the 
microscopical threshold of detection. The infectiousness of individuals with 
submicroscopical gametocyte densities was lower than that of children with microscopical 
gametocyte densities in terms of (i) prevalence of infection, (ii) proportion of infected 
mosquitoes and (iii) oocyst burden in mosquitoes. These observations are largely in 
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agreement with previous studies12,18 although a study in symptomatic children in Kenya 
reported that submicroscopical gametocyte carriers were as likely as microscopical 
gametocyte carriers to be infectious and only the average number of infected mosquitoes 
and the oocyst burden were lower for submicroscopical gametocyte carriers18. This 
difference may be due to the different populations: we enrolled asymptomatic children 
compared to the Kenyan study where children were sampled 14 days after a clinical malaria 
episode18. We nevertheless consider the current findings biologically more plausible since 
the chance of a submicroscopical gametocyte carrier being classified as ‘infectious’ (i.e. 
infecting at least one mosquito) is likely to be lower if submicroscopical gametocyte carriers 
on average infect a lower proportion of mosquitoes12,18. Contrary to a recently published 
hypothesis that infection of mosquitoes by submicroscopical gametocytaemia may be rare 
in areas of seasonal malaria transmission20, our findings suggest that carriers of 
submicroscopical gametocyte densities may be common in these circumstances. The 
relative contribution to transmission per gametocyte carrier may be lower for 
submicroscopical gametocyte carriers but their relative abundance in a population appears 
to counterbalance this and makes them important contributors to malaria transmission. To 
reliably determine the influence of transmission intensity and seasonality on the occurrence 
and infectiousness of submicroscopical gametocyte densities, a direct comparison is needed 
where the infectiousness of different populations is assessed at several time-points during 
the season.  
 
Our study has two limitations: we determined the infectious reservoir at the end of the wet 
season only and restricted our experiments to children. Seasonal patterns in gametocyte 
carriage22 make it impossible to draw conclusions about the importance of submicroscopical 
gametocyte carriage for malaria transmission at other time-points in the season. For this, a 
series of membrane feeding experiments are needed throughout the year. We have 
previously reported that submicroscopical gametocyte carriage is less prevalent in adults in 
our study area23. Our data can therefore not be extrapolated to the whole population. 
Although we observed a significant correlation between Pfs25 QT-NASBA gametocyte 
density and mosquito infection rates, it is not possible to reliably estimate the 
infectiousness of individuals based on gametocyte density data only. Some children with a 
gametocyte density below 1 gametocyte/µL were able to infect mosquitoes in our study. 
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This is surprising since a blood meal, that is on average 2-3µL, should contain at least one 
male and one female gametocyte to result in infection. However, the phenomenon has 
been observed before [18] and may be influenced by the aggregation of gametocytes that 
favours the encounter of males and females [28]. Alternatively, we cannot rule out that 
artefacts resulting from RNA degradation have resulted in unrealistically low estimates of 
gametocyte densities in occasional samples. We also observed that some carriers of 
gametocytes at high density were unable to infect mosquitoes8,12,18. This could be partly due 
to transmission reducing immune responses8,29. These immune responses may be inversely 
related to age18,29. Further studies should therefore be conducted at different time-points, 
include all age groups and preferably incorporate transmission reducing immune responses 
and sexing of gametocytes to further elucidate the detailed processes that determine the 
composition of the human infectious reservoir of malaria in a given transmission setting. 
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Summary 
Acquisition of immunity to P. falciparum sexual stages is a key determinant for reducing 
man-mosquito transmission by preventing the fertilisation and the development of the 
parasite in the mosquito midgut.  Naturally acquired immunity against sexual stages may 
therefore form the basis for the development of transmission blocking vaccines, but studies 
conducted to date offer little in the way of consistent findings. Here, we describe the 
acquisition of anti-gametocyte immune responses in malaria exposed individuals in Burkina 
Faso. A total of 719 blood samples were collected in a series of three cross-sectional surveys 
at the start, peak and the end of the wet season. The seroprevalence of antibodies with 
specificity for the sexual stage antigens Pfs48/45 and Pfs230 was twofold lower (22-28%) 
than that for an asexual blood stage antigen GLURP (65%) or for the pre-erythrocytic stage 
antigen CSP (54%). The youngest children responded at similar frequencies to all four 
antigens but, in contrast with the immune responses to GLURP and CSP that increased with 
age independently of season and area of residence, there was no evidence for a clear age-
dependence of responses to Pfs48/45 and Pfs230. Anti-Pfs230 antibodies were most 
prevalent at the peak of the wet season (p<0.001). Our findings suggest that naturally 
acquired immunity against Pfs48/45 and Pfs230 is a function of recent rather than 
cumulative exposure to gametocytes. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
88 
 
Introduction 
Malaria transmission depends on the presence of infectious sexual stage parasites in 
human peripheral blood, and naturally acquired immune responses to these or other stages 
can affect malaria transmission in several ways. An important indirect manner in which they 
influence malaria transmission is by reducing the number of asexual parasites that are the 
source of gametocytes. Immune responses can also influence malaria transmission more 
directly. Antibodies with specificity for sexual stages have been associated with a reduction 
of P. falciparum gametocyte prevalence in semi-immune individuals living in a hyper-
endemic area of Irian Jaya, Indonesia1. Early stage (stage I and IIa) gametocytes express the 
parasite protein PfEMP1 on the erythrocyte surface38 while recently identified proteins may 
be expressed in later developmental stages38,46. Immune responses against these 
gametocyte-derived surface antigens may be related to direct clearance of gametocytes47, 
and may explain why the duration of gametocyte carriage appears to decrease with age8. A 
third way in which antibody responses can affect transmission is by reducing the 
infectiousness of gametocytes once ingested by mosquitoes.  
 
Gametocytes in infected erythrocytes and gametes that emerge from erythrocytes inside 
the mosquito midgut express stage-specific antigens on their surfaces27,50. These antigens 
have a role in the fertilization or sporogonic development of malaria parasites in 
mosquitoes43,44. A proportion of gametocytes die in the human host without being passed 
on to a mosquito, thereby exposing sexual stage antigens to the human immune system.  
Sexual stage-specific antibodies may be elicited against these antigens31 and may play a role 
in transmission-blocking immunity by preventing fertilization or the development of 
sporogonic stage parasites in the mosquito4,7,18,20,21,42,44,49. These antibody responses may 
reduce the spread of malaria in human populations. A better understanding of naturally 
acquired sexual stage immunity is thus relevant to malaria control as it may form the basis 
for the development of malaria transmission blocking vaccines.  
Pfs230 and Pfs48/45 are major gametocyte and gamete surface antigens that induce 
antibody responses in naturally exposed individuals7,18,21,42,44 that are associated with 
functional transmission reducing immunity21,25,42,44.  
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Here, we describe the profiles of naturally acquired sexual stage immune responses to 
Pfs230 and Pfs48/45 in individuals from an area of intense seasonal malaria transmission in 
Burkina Faso. 
Methods  
Study site and population 
The study was conducted in a region close to Ouagadougou, the capital of Burkina Faso 
(West Africa), where malaria is endemic. Two areas of different endemicity16 were included 
in the study to test the effect of transmission intensity on sexual stage immunity. 
Plasmodium falciparum is the predominant malaria species in the region, accounting for 
90% of the infections; the remaining 10% being attributed to P. malariae and P. ovale24. 
The study’s participants are members of subsistence farming communities and all are 
permanent residents in the area. Participants were explained the procedures, risks and 
benefits involved in the study and their consent was obtained. The study protocol was 
viewed and received a written approval of the ministry of health of Burkina Faso (Research 
authorization number 2000/3174/MS/SG/DEP).  
 
Measurement of transmission intensity 
Repeated CDC light trap captures were carried out in both areas to estimate transmission 
intensity according to both area and season. Each area consisted of 3 grouped villages. 
Indoor mosquito captures extended from June to November 2002. The CDC light trap was 
placed close to the bed of the sleeper in randomly selected houses and mosquito capture 
was done from 7:00 pm to 6:00 am. Mosquito species were identified morphologically, 
counted and stored in tubes with silica gel. A representative sample of Anopheles gambiae 
mosquito thoraces and heads were examined for P. falciparum circumsporozoite protein 
(CSP) positivity index using routine CSP ELISA2. The monthly sporozoite rate was estimated, 
testing representative samples (approximately 50% of all caught mosquitoes from each trap) 
of randomly selected specimens of mosquitoes from each village. The entomological 
inoculation rate (EIR) was calculated as the product of the sporozoite rate by the biting rate.  
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Blood sample collection 
The seasonally-spaced cross-sectional surveys for parasitological and serological data 
collection  coincided with entomological data collection in 2002. At each survey, 
approximately 300 individuals (~150 from each area of residence) were randomly selected 
from village census lists aiming to include 60 individuals (10 per village) from each of five 
pre-defined age-groups: 1-4, 5-9, 10-14, 15-29 and 
individuals were invited to a sampling point and were systematically included until the 
required sample sizes were reached.  
For parasites counts, a blood slide film was made from finger prick blood of each individual. 
For specific anti-plasmodial antibody measurements, 500 µL finger prick blood samples 
were drawn. Plasma was separated by centrifugation and stored at –20°C before use. 
Subjects with fever (body temperature ≥37.5°C) were treated with an anti-malarial drug 
(CQ) following the national policy for malaria treatment in the year of 2002. 
 
Microscopical detection of P. falciparum parasites.  
Slides were read independently by two microscopists, each examining 100 microscopic 
fields, and the mean density was used. A third reader was involved when the first two 
readers disagreed about the prevalence or estimated densities differed ≥30%. In these cases 
the mean density of the two closest readings was used. Asexual stage and gametocyte 
densities were simultaneously assessed by counting against 1000 leucocytes in the thick 
smear. The lower limit of microscopy for gametocyte quantification was estimated at 5 
parasites/ converted to numbers of parasites per µL by 
assuming a standard count of 8000 leucocytes/µl of blood.  
 
Antigens  
Plasma IgG with specificity for Pfs48/45 and Pfs230 antigens derived from an extract of 
mature P. falciparum NF54 strain gametocytes were measured by ELISA (see below). For this 
purpose, mature gametocytes were produced in an automated static culture system in red 
blood cells of blood group O+ and non immune AB serum39 and harvested after 13-14 days. 
Gametocyte purification was previously described50. Briefly, mature gametocytes were 
isolated at 37°C to prevent their activation. Parasite culture was loaded on a cushion of 63% 
Percoll (GE-Healthcare:17-0891-01) and centrifuged for 30 min at 1,500g. The purified 
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gametocytes were then aliquoted and stored at –70°C before use.  For extraction of 
Pfs48/45 and Pfs230 enriched proteins, gametocytes were re-suspended in 1% sodium 
desoxycholate / TrisNaCl and 1mM phenylmethylsulfonyl fluoride (PMSF), incubated for 10 
min at room temperature and spin 13,000 rpm for 10 min. The supernatant was collected as 
Pfs48/45 and Pfs230-enriched antigens extract and diluted in 0.25% PBSTM (2.5% milk and 
0.05% tween20 in PBS) for use. The synthetic peptide NANP6 corresponding to the repeat 
region of the circumsporozoïte protein and the synthetic peptide GLURP GMP85-213 LR6748 
were used in standardized ELISA for sporozoite- and asexual blood stage-specific antibody 
detection respectively (see below).  
 
Pfs48/45 and Pfs230 IgG Enzyme Linked Immunosorbent Assays (ELISA) 
Samples selection 
Although samples for serology were available from almost all participants, it was not 
possible to screen all samples for the presence of sexual stage antibodies due to the labour 
intensiveness and costs involved in the necessary antigen preparation. ELISA was therefore 
performed on a representative sub-sample of randomly selected samples. For this purpose, 
samples were randomly selected from the list of available samples for each age-group and 
season separately. Initially, a number of 150 samples per season i.e. 25 in age groups 1-4 
and 5-9; 50 samples in age groups 10-19 and 
testing both Pfs48/45 and Pfs230 antigens. Samples sizes were approximately similar for 
both antigens tests at the start of the wet season (137 for Pfs48/45 and 136 for Pfs230), 
peak of the wet season (149 and 148 respectively) and end of the wet season (125 and 129 
respectively). To exclude possible variation in gametocyte antigen preparations, only 
samples that were concurrently tested for both Pfs48/45 and Pfs230 antigens extracted 
from the same batch of gametocytes were used for data analysis. This resulted in an overall 
130 samples at the start and end of the wet season and 150 at the peak of the wet season 
explaining the slight inconsistencies in the sample sizes between groups of seasons, age 
groups and areas of different endemicity. 
 
ELISA experiment 
The presence of anti-Pfs48/45 and anti-Pfs230 IgG antibodies in plasma samples was 
determined by coating 10µg/mL of anti-Pfs48/45 rat monoclonal antibody (mAb) 85RF45.345 
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or anti-Pfs230 rat mAb 63F6D7-F(ab)241, diluted in PBS, in the wells of 96-well polystyrene 
U-bottom ELISA-hard plates (Sterilin®, International Medical Products B.V., Zutphen, the 
Netherlands). Free sites were blocked with 5% milk (Marvel, Premier International Foods 
Ltd, Spalding, Lincs, United Kingdom) in PBS and Pfs48/45 and Pfs230 antigens contained in 
50 µL gametocyte extract (250,000 gametocytes equivalents/well) were captured by 
overnight incubation at 4°C. The buffer (0.25% PBSTM) used for dilution of gametocyte 
extract was added to control wells (i.e. no extract added) for background measurement. A 
dilution (1:100) in 0.25% PBS/TweenMilk of the test plasma was added to the wells 
prepared with and without antigen (control wells); and incubated for 2 hours at room 
temperature. The plate was washed and bound IgG antibodies were detected by addition of 
100µL of 1:30,000 diluted Goat-anti Human IgG-PO (H+L; Pierce) for 1h 30 min at room 
temperature. Wells were washed with PBS and subsequently incubated with tetramethyl 
benzidine (TMB) substrate solution for 20 min. The colour reaction was stopped with 4N 
H2SO4, and the optical density (OD) was read at 450 nm in an Anthos 2001 Microplate 
Reader (Labtec BV). All plasma samples were tested in duplicate. Three non-immune 
plasmas from Dutch blood bank donors as negative controls and one positive control plasma 
of a Dutch man that have been exposed to malaria for almost 30 years in sub-Saharan Africa  
were included per plate. The value for IgG titer (OD) of a sample was expressed as the 
difference in OD between the antigen and control wells. The cutoff was calculated as the 
mean OD of negative controls plus two standard deviations.  A sample was considered 
positive if its background-adjusted OD was above the cutoff.  
 
GLURP and NANP6 IgG ELISA   
To evaluate anti-asexual blood stage or anti-sporozoite antibody responses, 0.2µg/mL of 
GLURP85-213 in 0.05M carbonate buffer (50µL/well) or 1µg/mL of NANP6 in PBS (50 
µL/well) were coated in flat bottom high binding microtiter 96 well plates (NUNCTM 
Maxisorp, Nalge Nunc International Corp, Life Techn, The Netherlands) at 4°C. Coated plates 
were incubated overnight at 4°C and washed with PBST. Free sites were blocked with 150 
µl/well of 2.5% milk/PBS (Marvel). Subsequently, the blocker was washed off and plates 
incubated 1h at room temperature with 50 µl of 1:200 plasma diluted in PBSTM for GLURP 
ELISA or with 50 µl of 1:100 diluted plasma for anti-sprorozoitic ELISA. Plates  were washed 
and incubated for 1 hour with rabbit anti-human IgG-Peroxidase (Dako, P-214) diluted 
Immune responses to P. falciparum gametocytes 
 
93 
 
1:10,000 in PMSTM before reaction with the substrate (TMB). The staining was stopped 
after 15 min of reaction by 4N H2SO4 and the plate was read as described in Pfs48/45-
Pfs230 ELISA. Plasma was considered positive if the OD value was greater than two standard 
deviations above the mean of the negative control plasmas from Dutch blood bank donors.  
 
Statistical analysis 
Study participants were categorized into groups by age (1-4 years, 5-9 years, 10-19 years 
and tical analysis was performed using SPSS version 14.0 (SPSS Inc., 
Chicago, IL, USA). The influence of age on antibody prevalence was tested using logistic 
regression analyses using age in categories. Multivariate regression models allowed for 
confounding effects of age, season and area of residence. The Pearson 
comparing proportions and trends in dichotomous variables. Spearman’s rank correlation 
test was used to assess association between antibody levels of tested antigens. The level of 
significance was set at a two-tailed P < 0.05. 
The association between Pfs230 and Pfs48/45 antibody responses and functional 
transmission reducing activity (TRA) in the Standard Membrane Feeding Assay in previous 
studies (9, 11, 18) was presented after categorization of TRA as >50% and >90% reduction 
(9, 11, 18) and calculating odds ratios (OR) with 95% confidence intervals (95% CI). 
 
Results 
Entomology  
A representative sample of  4525 mosquitoes was tested for transmission intensity 
estimates. EIR details per season and area of residence are summarized in Table 1. Overall, 
the mean EIR was estimated to be 28.5 infective bites/person/month (ib/p/m) in the whole 
study area and this varied by season (1.47; 69.57; and 14.67 ib/p/m at start, peak and end-
wet season, respectively) and area of residence (52.4 ib/p/m versus 3.05 ib/p/m).   
Parasitology 
A total of 719 blood slide samples were collected over the three cross-sectional 
surveys. At the site with the highest endemicity, 147, 101 and 130 samples were collected at 
the start, peak and end of the wet season, respectively. At the site of lower endemicity, 
these figures were 149, 50 and 142, respectively. The overall proportion of individuals 
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harbouring asexual parasites was 63.4% (456/709); while 18.9% (136/709) carried 
gametocytes. There was a significant age-dependent decrease in both prevalence of asexual 
parasites (OR = 0.54, p < 0.001, 95% CI 0.46-0.63) and gametocytes (OR = 0.61, p < 0.001, 
95% CI 0.51-0.74) and in the density of asexual parasites (β = -0.027, se(β) = 0.003, p < 
0.001) and gametocytes (β = -0.009, se(β) = 0.022, p = 0.004) after adjustment for season 
and area of residence.   
Parasite prevalence and density showed seasonal fluctuations. The prevalence of 
asexual parasites was significantly higher at the peak compared to the start (p < 0.001) and 
the end of the wet season (p = 0.004). Similarly we observed a higher asexual parasite 
density at the peak compared to the start (p < 0.001) and the end of the wet season (p = 
0.01). Details on gametocyte prevalence are presented in Table 1. Similar to asexual 
parasites, gametocytes were more prevalent at the peak (28.5%, 43/151) compared to the 
start of the wet season (22%, 65/296) (p = 0.1) and were least prevalent at the end of the 
wet season (10.3%, 28/272) (p < 0.001). The median density of gametocytes/
higher at the peak (24, IQR 24-72) compared to the start (24, IQR 16-40) (p=0.03) and, at a 
borderline level of significance, lower compared to the end of the wet season (40, IQR 40-
57) (p = 0.09). Despite a substantial difference in EIR between them, there was no significant 
variation in asexual parasite and gametocyte prevalence between the study areas. The 
prevalence of asexual parasites was 61% (208/341) in the low transmission area and 65.6% 
(248/378) in the high transmission area (p = 0.2). The distribution of gametocytes in both 
areas is shown in Table 1. The proportion of gametocytes carriers was 17% (60/341) in the 
low transmission area and 20.1% (76/378) in the high transmission area (p = 0.4). This 
equality in parasite prevalence could reflect the high endemicity of malaria across the entire 
area (16). 
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Table 1. Entomological inoculation rates and gametocyte indices in the study population.  
 
Season  Start wet Peak wet End wet 
Number of traps Low endemic 36 
 
51 54 
 High endemic 36 
 
50 53 
EIR, (95% CI) Low endemic 0.0 
 
9.16 0.0 
 High endemic 2.9  
 
129.9 29.3  
Gametocyte prevalence   1-4  years, % (n/N) Low endemic 20.0 (6/30) 
 
40.0 (4/10) 24.0 (6/25) 
 High endemic 43.3 (13/30) 
 
42.9 (9/21) 14.8 (4/27) 
                                               5-9 years, % (n/N) Low endemic 30.0 (9/30) 
 
40.0 (4/10) 9.7 (3/31) 
 High endemic 34.5 (10/29) 
 
36.8 (7/19) 6.9 (2/29) 
                                           10-19 years, % (n/N) Low endemic 17.3 (9/52) 
 
42.1 (8/19) 13.7 (7/51) 
 High endemic 26.5 (13/49) 
 
22.9 (8/35) 5.9 (2/34) 
                                              20+ years, % (n/N) Low endemic 2.7 (1/37) 
 
9.1 (1/11) 5.7 (2/35) 
 High endemic 10.3 (4/39) 
 
7.7 (2/26) 5.0 (2/40) 
Total  22.0 (65/296) 28.5 (43/151) 10.3 (28/272) 
Low endemic = area with lower endemicity; high endemic = area with higher endemicity 
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Table 2. Factors associated with antibody prevalence to P. falciparum pre-erythrocytic and 
asexual blood stage antigens (2A) and sexual stage antigens (2B). 
2A 
   NANP-6  GLURP  
  Univariate 
Odd ratio  
(95% CI) 
Multivariate 
Odd ratio  
(95% CI) 
Univariate 
Odd ratio 
(95% CI) 
Multivariate 
Odd ratio  
(95% CI) 
Age 
 
1-4 yr 
N 
1 (ref) 
127 
1 (ref) 1 (ref) 
142 
1 (ref) 
 5-9 yr 
 
N 
2.51  
(1.48-4.25) 
144 
2.57 
(1.51-34.38) 
4.88 
(2.96-8.04) 
147 
4.88 
(2.96-8.04) 
 10-19 yr  
 
N 
4.05  
(2.49-6.59) 
230 
4.29 
(2.62-7.03) 
5.60 
(3.56-8.82) 
236 
5.59 
(3.55-8.80) 
 20+ yr  
 
N 
16.27  
(9.19-28.82) 
175 
17.16 
(9.61-30.62) 
6.44 
(3.96-10.48) 
184 
6.46 
(3.97-10.51) 
Season Start wet 
N 
1 (ref) 
269 
1 (ref) 1 (ref) 
293 
 
 Peak wet 
 
N 
6.57 
(3.96-10.91) 
143 
10.59 
(5.91-18.98) 
 
0.75 
(0.50-1.14) 
148 
 
 End wet 
 
N 
1.18 
(0.84-1.66) 
264 
1.33 
(0.90-1.96) 
0.96 
(0.67-1.36) 
268 
 
Area Low tran. 
N 
1 (ref) 
326 
1 (ref) 
 
1 (ref) 
337 
 
 
 High tran. 
 
N 
1.73 
(1.27-2.35) 
350 
1.93 
(1.38-2.71) 
0.92 
(0.67-1.25) 
372 
 
Asexual Absent 
N 
1 (ref) 
244 
 1 (ref) 
259 
 
 Present 
 
N 
0.72  
(0.53-0.99)  
432 
 1.08  
(0.79-1.49) 
450 
 
Gametocyte Absent 
N 
1 (ref) 
544 
1 (ref) 1 (ref) 
575 
1 (ref) 
 Present 
 
N 
0.57  
(0.39-0.84) 
132 
0.62  
(0.38-1.00) 
0.52 
(0.35-0.76) 
134 
0.58  
(0.38-0.90) 
ref=reference; tran.=transmission intensity; sero-reactivity related to a given variable was 
adjusted for all others variables that primarily play a significant role in the univariate model 
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2B  
 
   Pfs48/45  
 
 Pfs230  
  Univariate 
Odd ratio  
(95% CI) 
Multivariate 
Odd ratio  
(95% CI) 
Univariate 
Odd ratio  
(95% CI) 
Multivariate 
Odd ratio  
(95% CI) 
Age 1-4 yr 
N 
1 (ref) 
85 
1 (ref) 1 (ref) 
84 
1 (ref) 
 5-9 yr 
 
N 
0.17 
(006-0.47) 
84 
0.16 
(0.06-0.47) 
0.27 
(0.12-0.58) 
83 
0.27 
(0.12-0.58) 
 10-19 yr 
  
N 
0.53 
(0.28-1.03) 
138 
0.52 
(0.26-1.00) 
 
0.74 
(0.42-1.31)  
137 
0.74 
(0.41-1.31) 
 20+ yr 
 
N  
1.65 
(0.89-3.05) 
108 
1.67 
(0.89-3.11) 
0.65 
(0.35-1.19) 
105 
0.64 
(034-1.18) 
Season Start wet 
N 
1 (ref) 
137 
 1 (ref) 
136 
1 (ref) 
 Peak wet 
 
N 
1.35 
(0.78-2.32) 
149 
 4.92 
(2.85-8.50) 
148 
4.93 
(2.85-8.52) 
 End wet 
 
N 
0.69 
(0.37-1.28) 
129 
 0.73 
(0.37-1.44) 
125 
0.73 
(0.37-1.45) 
Area Low tran. 
N 
1 (ref)140  1 (ref) 
138 
 
 High tran. 
 
N 
0.69 
(0.43-1.12) 
275 
 1.20  
(0.76-1.91) 
271 
 
Asexual Absent 
N 
1 (ref) 
131 
 1 (ref) 
128 
 
 Present 
 
N 
0.65  
(0.40-1.05) 
284 
 0.98  
(0.62-1.55) 
281 
 
Gametocyt
e 
Absent 
N 
1 (ref) 
326 
 1 (ref) 
321 
 
 Present 
 
N 
0.72  
(0.40-1.31) 
89 
 1.06  
(0.63-1.78) 
88 
 
ref=reference; tran.=transmission intensity; sero-reactivity related to a given variable was 
adjusted for all others variables that primarily play a significant role in the univariate model 
 
Serology  
Plasma samples were screened for antibody response profiles in the population and 
related to age (Figure 1), season (Figure 2) and area of residence (Figure 3). The average 
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prevalence of IgG antibodies was 54.3% (367/676) for the sporozoite antigen NANP6 and 
64.9% (460/709) for the asexual blood stage antigen GLURP. In contrast to sporozoite and 
asexual blood stage antigens, sexual stage-specific antibody responses were only detected 
in a minority of the samples: 22.2% (92/415) contained anti-Pfs48/45 IgG and 28.6% 
(117/409) anti-Pfs230 IgG. 
Effect of age on antibody responses  
Among children below 5 years, the prevalence of antibodies with specificity for NANP6 
(23.6%) and GLURP (32.4%) was broadly similar to those for Pfs48/45 (27.1%) and Pfs230 
(38.1%). As expected, the prevalence of asexual stage antibodies to NANP6 and GLURP 
increased significantly with age (Adjusted OR = 2.35, p < 0.001, 95% CI 1.98-2.78; Adjusted 
OR = 1.79, p < 0.001, 95% CI 1.53-2.08 respectively) reflecting cumulative exposure to 
infection, while no evidence of an age-dependent increase in sexual stage-specific antibody 
responses was observed (Table 2). 
 
Figure 1. Prevalence of antibodies against pre-erythrocytic stage (NANP6), asexual blood 
stage (GLURP) and sexual stage (Pfs48/45 and Pfs230) in relation to age.  
The error bars show the ± limits of the 95% confidence intervals.  The number of plasma samples 
tested per age group (1-4, 5-9, 10-19 and  20 years of age) are  127, 144, 230 and 175 for NANP6; 
142, 147, 236, 184 and 184 for GLURP; 85, 84, 138 and 108 for Pfs48/45 and 84, 83, 137 and 105 for 
Pfs230 respectively. 
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 The seroprevalences for Pfs48/45 and Pfs230 in the youngest children (27.1% and 38.1% 
respectively) were comparable to those in adult (38% and 28.6% respectively). However, 
there was a significant decline of Pfsf48/45- and Pfs230-specific antibody prevalence from 1-
4 year-olds to  5-9 year-olds ( 2 = 13.61, p = 0.001 and 2 = 12.02, p < 0.001 respectively) 
followed subsequently by a significant increase with increasing age (OR = 3.09, p < 0.001, 
95% CI 2.02-4.71 and OR = 1.41, p = 04, 95% CI 1.01-1.97 respectively) (Figure 1). 
 
Differences between seasons and areas  
GLURP antibody responses showed no variation according to season or area whilst, 
conversely, the prevalence of NANP6 antibodies differed by both season (Figure 2) and area 
of residence (Figure 3). Antibodies with specificity for NANP6 were detected in 83.9% of 
individuals at the peak wet season while this proportion was significantly lower at the start 
(44.2%) and at the end (48.5%) of the wet season. Thus the prevalence of NANP6 antibodies 
at the peak wet season was significantly higher than either at the start ( 2= 60.34, p < 0.001) 
or the end of the wet season ( 2 = 48.91, p < 0.001). There was also a difference in NANP6 
antibody prevalence between the area of high transmission (60.9%) and the area of lower 
transmission (47.2%; 2 = 12.61, p < 0.001).  
The prevalence of sexual stage-specific antibodies in relation to season is presented in 
Figure 2. 
Pfs48/45 antibody prevalence increased at the peak of the wet season (27.5%) but did not 
significantly differ from the prevalence at either the start (21.9%) or the end of the wet 
season (16.3%). The variation in Pfs230-specific antibody prevalence was significant, 
reaching 51.4% at the peak compared to 17.6% at the start ( 2 = 35.29, p < 0.001) and 13.6% 
at the end of the wet season ( 2= 42.99, p < 0.001). This increased Pfs230 antibody 
prevalence at the peak of the wet season remained significant after adjustment for age 
(Adjusted OR = 4.93, p < 0.001, 95% CI 2.85-8.52, Table 2). Both antigens are on the surface 
of the gametocyte and were expected to have shown similar patterns of immune response. 
The difference observed in their immune responses may be dependent on the difference in 
their immunogenicity, Pfs230 being more immunogenic than Pfs48/45 (22). 
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Figure 2. Prevalence of antibodies against NANP6, GLURP, Pfs48/45 and Pfs230 in relation 
to season. Bars indicate the proportion of positive individuals in each area of residence. Error bars 
indicate the upper limit of the 95% confidence interval around the proportion. The number of 
individuals (with antibodies) during the different seasons was: start-wet season: 119 (269) for 
NANP6, 195 (293) for GLURP, 30 (137) for Pfs48/45, 24 (136) for Pfs230; peak-wet season: 120 (143) 
for NANP6, 89 (148) for GLURP, 41 (149) for Pfs48/45 and 76 (148) for Pfs230; end-wet season: 128 
(264) for NANP6, 92 (176) for GLURP, 17 (125) for Pfs48/45 and 21 (129) for Pfs230. 
 
In terms of area of residence, there was no difference in the prevalence of antibodies with 
specificity for either Pfs48/45 or Pfs230 (Table 2). 
  
Figure 3. Prevalence of antibodies against NANP6, GLURP, Pfs48/45 and Pfs230 in relation 
to the area of residence. Bars indicate the proportion of positive individuals in each area of 
Immune responses to P. falciparum gametocytes 
 
101 
 
residence. Error bars indicate the upper limit of the 95% confidence interval around the proportion. 
The number of positive individuals in both area of residences was: high transmission area: 213 (350) 
for NANP6, 238 (372) for GLURP, 55 (275) for Pfs48/45 and 81 (271) for Pfs230; low transmission 
area: 154 (326) for NANP6, 222 (337) for GLURP, 37 (140) for Pfs48/45 and 36 (138) for Pfs230.  
 
The relationship between antibody responses and parasite carriage is shown in Table 2. 
Both anti-NANP6 and anti-GLURP immune responses were significantly higher in individuals 
negative to gametocytes (Adjusted OR = 0.62, 95% CI 0.38-1.00, p = 0.04 for NANP6 and 
Adjusted OR = 0.58, p = 0.01, 95% CI 0.38-0.90 for GLURP).The seroprevalences for Pfs48/45 
and Pfs230 antibodies were not influenced by the concurrent presence of asexual parasites 
or gametocytes. 
 
Correlation of antibody responses between the different antigens  
We also examined the correlation between antibody responses at the individual level. As 
presented in Table 3, the levels of antibody directed to NANP6 and Pfs230 and those to 
Pfs230 and Pfs48/45 were strongly correlated (p ≤ 0.001.) Antibody levels to GLURP were 
associated with those to NANP6. 
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Table 3. Spearman rank correlation of level of anti-sporozoite and anti-asexual blood 
stage antibody with level of anti-sexual stage antibody. 
 
r = spearman correlation coefficient; N = number of individuals. Paired NANP6-GLURP, NANP6-Pfs230 and 
Pfs48/45-Pfs230 data showed strong correlations (p ≤ 0.001). 
 
Table 4. The association between sexual stage antibody prevalence and functional 
transmission reducing activity in three studies using the same ELISA methodology. 
 
  Sexual stage antibody responses 
 Pfs48/45 antibody 
prevalence (n=350) 
Pfs230 antibody prevalence 
(n=344) 
Functional transmission 
reducing activity 
OR (95% CI) p-value OR (95% CI) p-value 
 >50% reduction 3.76 (2.27-
6.23) 
<0.001 1.87 (1.18-
2.96) 
0.007 
 >90% reduction 6.08 (3.21-
11.49) 
<0.001 2.84 (1.47-
5.50) 
0.002 
This summary table combines data from Tanzania and Indonesia (9, 11, 18) that used identical ELISA protocols 
and related antibody prevalence to functional transmission reducing activity (i.e. the percentage reduction in 
mosquito oocyst numbers in test samples compared with controls) in standard membrane feeding assays. 
OR=odds ratio; 95% CI=95% confidence interval 
 
 
 
 NANP6 r (P-value)  
N 
GLURP r (P-value)  
N 
Pfs48/45 r (P-value)  
N 
Pfs230 r (P-value)  
N 
NANP6   0.209 (<0.001)  
671 
0.53 (0.29) 
390 
0.170 (0.001) 
384 
GLURP    -0.067 (0.17) 
  
413 
-0.039 (0.43) 
407 
Pfs48/45    0.414 (<0.001) 
409 
Pfs230     
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Discussion 
As in previous studies6,9,18,23,26,43,44, we found evidence for naturally acquired immunity 
against P. falciparum sexual stages. Overall, 22 to 28% of our samples were positive for 
sexual stage-specific antibodies while 54 to 65% were positive for pre-erythrocytic- and 
asexual blood stage-specific antibodies. Unlike immune responses to NANP6 and GLURP, we 
found no evidence for age as a predictor for anti-Pfs48/45 and anti-Pfs230 antibody 
responses. Our data do reveal that sexual stage-specific antibody responses increase 
markedly during the transmission season. This would indicate a role for recent exposure to 
parasite antigens in the short-term boosting of sexual stage-specific immunity, although this 
requires confirmation in longitudinal studies.  
 
The lower prevalence of sexual stage-specific antibodies compared with either pre-
erythrocytic- or asexual stage-specific antibodies in the same study population confirms 
previous findings6,13,18. In contrast to antibodies directed to sexual stage antigens, those 
directed to an asexual blood stage antigen (GLURP) increased with age, as described 
before14,15,17,19,32, with no apparent season-dependent changes17,19. This would suggest that 
anti-GLURP antibody responses are both long-lived and stable even when antigen exposure 
decreases in the low transmission season and/or with increasing age. If sexual stage-specific 
antibody responses persisted in the absence of boosting, we would expect to see a similar 
pattern of increasing antibody prevalence with increasing age, but, despite a significant 
increase in the prevalence of sexual stage-specific antibodies from 5-9 years of age onward 
in our population, the close similarity of the prevalences in the youngest children and in 
adults above 20 years old of age effectively obscured any such association.  
A single recent study reported an age-dependent increase of sexual stage-specific antibody 
responses, although it should be noted that that study concerned pre- and post-treatment 
determinations in residents of an area with a very low rate of transmission and is therefore 
not directly comparable with the study we report here11. The results of other studies of the 
age-dependence of such responses are inconsistent6,18,30. In Cameroon, the level of 
transmission blocking immunity, as measured in membrane feeding experiments, was not 
related to age3,5. The lack of age-dependence of sexual stage-specific antibody responses 
has often been attributed to their short-lived nature and hence a requirement for frequent 
boosting30,40. Cumulative immune memory, likely the result of repeated exposure to 
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infections, is thought to form the basis of the age-dependent increase of asexual blood 
stage-specific immune responses51. Immature and/or short-term memory for responses 
directed to sexual stage antigens is plausible30 and possibly explained by a predominantly T-
cell independent induction of the immune response29.  
Interestingly, the prevalence of sexual stage-specific IgG responses in the youngest children 
in our study group was similar to that for the asexual (GLURP) and pre-erythrocytic (NANP6) 
antigens, suggesting that sexual stage-specific immune responses may readily develop in 
response to antigen exposure early in life. Since age-related cumulative exposure seems to 
have little effect on sexual stage immune responses, we speculate that the greater 
prevalence in young children may reflect the initial immune response to gametocytes as 
observed in individuals after a single or limited number of exposures to infection with either 
P. falciparum6,22,33 or P. vivax31. The remarkable nadir in both Pfs48/45 and Pfs230 
seroprevalences in children aged 5-9 years old was previously observed in populations 
exposed to endemic malaria. The studies found that sexual stage immune responses 
decreased with age in the younger age groups but there was no further decline in older age 
groups6,18. Sexual stage antibody responses in young children are likely to be the result of 
high gametocyte exposure in this age group. In older children, gametocyte exposure 
decreases, possibly explaining the reduction in antibody prevalence. In adults gametocyte 
exposure may be lowest but sexual stage commitment during infections may be relatively 
increased34 and antibody responses to sexual stage antigens may become more long-lived, 
reflecting a maturation of the immune response.  
 
An important finding from the study reported here is that sexual stage-specific antibody 
responses may vary with season. Pfs230-specific antibody prevalence, in particular, 
increased during the peak of the transmission season, suggesting that the level of sexual 
stage-specific antibodies may reflect recent exposure. A possible association between sexual 
stage immunity and recent antigen exposure is also suggested by the correlation between 
NANP6 and anti-sexual stage antibodies. In contrast to those directed to GLURP, NANP6-
specific antibody responses seemed to be short-lived. Thus the pattern of variation in 
NANP6 antibody responses closely reflected the seasonality of transmission in our study, 
indicating that seroreactivity to NANP6 is dependent on recent exposure and therefore 
highly susceptible to changes in sporozoite exposure. The close association we observed 
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between NANP6-and Pfs230-specific antibodies may be an indication that the immune 
responses to sexual stage antigens are therefore also related to recent exposure to 
infection, explaining the seasonality of the anti-Pfs230 antibody response. Our results 
showed that many infections with asexual parasites are accompanied by gametocytes35,37 
and this proportion will be further increased if sub-microscopic gametocyte densities are 
considered10. Since asexual parasite carriage increases during the transmission season36, 
exposure to gametocytes increases in parallel, possibly explaining the seasonality of anti-
sexual stage IgG responses. However, the seasonality of sexual stage-specific immune 
responses28 has been rarely studied, making any comparison difficult. The importance of 
recent exposure to infection for the acquisition of sexual stage-specific immunity has been 
reported from previous studies in which the prevalence of anti-Pfs48/45 and anti-Pfs230 
antibodies increased in migrants from a non-endemic to an endemic area9 and where 
functional transmission reducing immunity was shown to increase during the transmission 
season12. We did not determine functional transmission reducing immune responses in the 
current dataset. Three studies that used the same methodology for determining total IgG 
antibody responses to Pfs48/45 and Pfs230 did relate these responses to functional 
transmission reducing activity (TRA) in the standard membrane feeding assay9,11,18. When 
combined, these data show a strong association between Pfs48/45 and Pfs230 antibody 
prevalence and different levels of TRA (Table 4). These data support the current findings on 
sexual stage antibody responses that plausibly reflect associations between functional TRA 
and age, season and recent exposure to malaria antigens. 
 
We further tried to explore the relevance of recent exposure for the acquisition of parasite 
stage-specific immunity by relating antibody responses to concurrent asexual parasite and 
gametocyte carriage. Our results showed that NANP6 and GLURP –specific antibodies appear 
to negatively associate with gametocytes suggesting that immune responders to these two 
antigens are more likely to have a shorter period of asexual parasite carriage that will 
translate in a lower likelihood of gametocyte carriage. However, we found no effect of anti-
Pfs48/45 or anti-Pfs230 antibodies on gametocyte carriage. Concurrent gametocytes may be 
positively related to development of sexual stage-specific immune responses11 although a 
straightforward relationship is not always evident6,18. Immune responses to gametocyte 
antigens induced prior to sampling may persist for several weeks after gametocyte 
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clearance11 or following reduction of gametocytaemia to sub-microscopic levels, whilst 
acquisition/boosting of responses to gametocytes circulating at the time of sampling may 
take longer e.g. after their death/destruction and subsequent clearance. Intuitively, then, an 
antibody response that is boosted by recent gametocyte antigen exposure can better be 
determined in studies that determine gametocyte carriage at both microscopic and 
submicroscopic level repeatedly and relate sexual stage-specific antibody responses to 
previous as well as current gametocyte exposure. 
 
In summary, plasma samples from malaria exposed individuals were analyzed to provide 
indications of the development of naturally-acquired immunity to P. falciparum sexual 
stages. Our findings indicate that sexual stage-specific immune responses are naturally 
acquired in the study population and that they are a function of recent rather than 
cumulative exposure to gametocytes. This occurs after limited exposures to gametocytes in 
the youngest age-groups, but boosting is also evident during the peak of the transmission 
season. A next step would be to determine the functional importance of sexual stage-
specific antibody responses in this population that, despite developing both asexual and 
sexual stage-specific antibody responses, is repeatedly exposed to intense transmission35,36. 
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The work reported in this thesis describes the prevalence of gametocytes in human 
populations in Burkina Faso and factors related to their transmission from man to mosquito. 
Gametocyte detection in human blood samples is primarily based on microscopy and has 
included the more sensitive molecular technique Pfs25 QT-NASBA to quantify sub-
microscopical gametocytaemia. The infectiousness of gametocytes in the field is determined 
by direct membrane feeding assays and the contribution of both microscopical and sub-
microscopical gametocytaemia to malaria transmission. Antibody responses against 
transmission blocking vaccine candidate antigens Pfs48/45 and Pfs230, important 
modulators of gametocyte infectivity, are detected in field sera and their implication in 
transmission reducing activity (TRA) discussed. The overall results are integrated in a final 
discussion on their relevance for malaria transmission reducing interventions, malaria 
control and elimination strategies.     
 
7.1. The epidemiology of Plasmodium falciparum gametocytes 
Gametocytes and Anopheles mosquito vectors are the two components necessary for 
malaria transmission in humans. Successful malaria transmission from man to mosquito 
depends on the presence of infectious gametocytes in the peripheral blood of the human 
host. It is well acknowledged that targeting gametocytes either alone or following the 
introduction of control interventions will contribute to reducing malaria transmission and 
thereby assist in lessening malaria associated morbidity and mortality1-3.    
In Chapter 2 of this thesis, we determined whether season plays a role in the prevalence of 
gametocytes in an area of high malaria endemicity in Burkina Faso. Knowledge of seasonal 
gametocyte distribution can contribute to the appropriate design of interventions; correctly 
timed transmission reducing interventions may allow a more efficient reduction of malaria 
transmission. In our study, approximately one fifth of the study population harbored 
gametocytes as detected by microscopy. There was a clear increase in the prevalence and 
density of gametocytes during the peak transmission season (peak of the rainy season) 
compared to the period when transmission was practically absent (dry season). At the peak 
transmission season, we observed a positive association between gametocyte prevalence 
and density with asexual parasite density. This positive association between gametocytes 
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and high densities of asexual parasites is not novel4-7. In a low endemic area of Sudan, a 4-
fold increase from the dry season to the wet season has been observed in the prevalence of 
gametocytes10. In areas with different malaria endemicity in Tanzania, the proportion of 
gametocyte carriers increased significantly from the dry to the wet season with a difference 
of 4 to 21%11,12. In Cameroon, similar seasonal trends in gametocyte prevalence have also 
been observed10,13,14.  Most adults carrying gametocytes concurrently carried low densities 
of asexual parasites8,9 suggesting that gametocyte carriage is not always associated on high 
asexual parasite densities2. Asexual parasite density is possibly not the only signal that 
drives gametocyte prevalence at the peak transmission season, since human immune 
responses that target asexual blood stage replication, induced by super-infections (a new 
infection establishing in parallel with an existing one) during the wet season10,15 may also 
increase gametocyte production. Although not monitored during our study, it is also 
possible that hematological disruptions like anemia, commonly observed in children 
exposed to intense transmission, associate with high gametocyte prevalence7,16,17 during the 
wet transmission season. 
The two-fold increased gametocyte prevalence at the start of the wet season compared to 
that during the dry season is intriguing. This rise appeared to be independent of an 
increased exposure to sporozoites (which occurred after the start of the transmission 
season), age or asexual parasite density. We hypothesized that uninfected mosquitoes bites, 
particularly more common during this period of the year, may induce gametocyte 
production. This association was previously  suggested18 and would indicate an adaptation 
of parasites to ensure that an up-regulation of gametocytogenesis strategically coincides 
with an increase in the presence of mosquitoe bites to maximize transmission efficiency. 
However, recent studies by Billingsley and colleagues19 and Shutler and colleagues20 
reported equivocal results on gametocyte production rates after mosquito probing 
indicating that the association between sexual stage commitment and mosquito bites needs 
confirmation in future studies, as well as the elucidation of the possible stimulus for 
gametocytogenesis. 
Our findings also reveal that age drives gametocyte distribution. We further looked 
at this age effect in Chapter 3 and 4 using the molecular QT-NASBA technique for 
gametocyte detection. In Chapter 3, gametocyte prevalence and density were found to vary 
with age both by microscopy and QT-NASBA9,21. Our finding that gametocyte carriage is 
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negatively related to age, being more common in younger individuals, is supported by 
several studies4,5,11,13-15,22,23. Our data suggest that asexual parasite densities may primarily 
be responsible for the age-related decrease of gametocyte prevalence being an indirect 
consequence of the age related-decrease of asexual parasite densities9. We hypothesize 
that asexual stage immunity that gradually increases with age is accompanied by asexual 
parasite clearance that ultimately result in a lower prevalence of gametocytes in adults. 
However this seems somehow to be compensated by an increase gametocyte production 
with age as observed in Chapter 4. 
In Chapter 4, we try to verify the above mentioned hypothesis by determining whether the 
age-related decrease of gametocyte carriage is a consequence of an age-dependent 
clearance of asexual parasites2 or if there may be an age-dependent production of 
gametocytes. We observed that the proportion of gametocyte carriers relative to the total 
parasite population in increased in adults compared with the youngest children both by 
microscopy (from 1.8% to 18.2%) and by QT-NASBA (0.5% to 5.7%). Individuals that carry 
only gametocytes also increased in proportion from children (13.4%) to adults (45.6%). In 
subjects carrying only gametocytes, all asexual parasites may have converted to 
gametocytes or may have been cleared either by treatment or by partial immunity. Because 
antimalarial treatment is a rare event in adults and naturally acquired immunity is not 
sterilizing, this may suggest that asexual parasites declined to submicroscopical level while 
induced gametocytaemia persisted for several months24-26. This actually demonstrates that 
gametocyte production increases with increasing age independent of asexual parasite 
carriage that itself decreases with increasing age. From our epidemiological study, it is 
difficult to directly identify the cause for this increase in gametocyte production with age. 
Although we overall observed an age-related increase of gametocyte production, it is clear 
that gametocyte carriage stabilizes at a lower level in adults compared to children likely 
because of the lower carriage of their generators, i.e. the asexual parasites. A plausible 
explanation for this increase in gametocyte production in adults would be that fitness 
advantages for the parasite may increase the shift from asexual parasite to gametocyte in 
response to stressful conditions commonly observed in adults and possibly related to age-
acquired immunitythat negatively affect asexual stage parasite multiplication. Together with 
findings from chapter 3, this indicates that asexual parasites may be the main drivers of 
gametocyte carriage but an age-dependent increase in gametocytogenesis could be an 
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(incomplete) compensatory mechanism for the lower asexual parasite densities in older 
individuals.  
Due to their overall higher representation in the total population, our findings suggest that 
the contribution of adults to the human infectious reservoir is probably substantially greater 
than appreciated to date under the assumption that these low gametocytaemias remain 
infectious.  
 
7.2. The contribution of submicroscopic gametocyte carriage to malaria 
transmission 
When gametocyte carriers are identified in field studies, gametocyte densities in the 
peripheral blood are at least an order of magnitude lower than those of asexual 
parasites4,5,9,14,17,21,27,28. Little is known about the reasons for this paucity of gametocytes as 
compared to asexual parasites in endemic areas29. There is some evidence that gametocyte-
specific immune responses can down-regulate gametocytaemia independent of asexual 
stage-specific30 immunity but the nature and targets of such functional immunity have not 
been identified. At least part of the low gametocyte prevalence can be explained by the 
relative insensitivity of microscopy for detecting gametocytes. In our study, thick smears 
were read by two independent microscopists and gametocytes counted against 500 
leucocytes in 100 microscopic fields with a limit of detection of 16 gametocytes/ L. 
Consequently, individuals with less than 16 gametocytes/ L were unlikely to be detected by 
microscopy. In this context, false negative gametocytaemia is not a rare event26. We 
determined the relevance of this phenomenon by asking several readers to read the same 
slide for gametocytes (figure 1).  
The likelihood of gametocyte detection increased substantially with increasing the number 
of observers. Our results demonstrate our routine standard protocol (2 miscroscopists once 
read the same slide) detected gametocytes in 18% of the slides while this increased to 33% 
when 5 microscopists read the same slide twice.  Although this finding indicates that 
gametocyte detection by microscopy can be improved, this will substantially increase the 
workload for an already laborious technique and the reliability of the final result is still 
dependent on the experience of the slide readers.   
 
 Chapter 7    
116 
 
 
Figure 1: The rate of gametocyte positivity as determined by microscopy increases with 
increasing the number of slide readers. Each slide has been read twice by all the 5 readers 
(i.e. the maximum number of times a slide was read was 10 times); there was variation in 
the microscopic fields that were examined. 
 
These limitations demonstrate the low sensitivity of microscopy and its inaccuracy in 
gametocyte quantification at very low concentrations. The prevalence of gametocytes in 
malaria endemic areas is grossly underestimated when using standard microscopy.  
In Chapter 3, Pfs25 Real-Time QT-NASBA, which has a lower detection limit of 20-100 
gametocytes/mL31 and 10 asexual parasites/mL32, is used to detect and quantify gametocyte 
density. Pfs25 QT-NASBA in our study confirmed the age-related pattern in the prevalence 
of gametocytes that was previously reported by microscopy4,5,14,15,22. The overall prevalence 
of gametocytes as detected by microscopy (~20%) increased 3.3 fold by QT-NASBA to 70%, 
indicating that a considerable proportion of gametocyte carriers is missed by microscopy 
(Chapter 3)9. In a highly endemic area in Kenya, gametocyte prevalence in clinical malaria 
cases was reported to be 86% by QT-NASBA compared to 22% by microscopy. In a low 
transmission setting of Tanzania, the prevalence of sub-microscopical gametocytaemia 
reached 15% in the general population while an estimate by microscopy indicated only ~1% 
gametocyte carriers33. These findings provide evidence that sub-microscopical gametocyte 
carriers are common in endemic areas and may be relevant for malaria transmission. We 
next investigated this issue by directly determining the infectivity of microscopic and 
submicroscopic gametocyte carriers by membrane feeding assays. This was the first study to 
use molecular gametocyte detection tools in combination with direct assessment of 
gametocyte infectivity in a general population.  
 
 General discussion 
117 
 
In Chapter 5, we used direct membrane feeding experiments to determine the 
infectiousness of malaria exposed children and subsequently the contribution of 
microscopical and sub-microscopical gametocytaemia to transmission. Blood was offered to 
mosquitoes via a thin stretched artificial membrane attached to a water-jacketed glass 
feeder maintained at 37°C. During the entire process, mosquitoes were handled gently to 
reduce stress which may increase mosquitoes’ mortality and affect the final results. 
Mosquitoes were allowed to feed during 10-15 min and dissected 7-8 days later for oocyst 
detection. The findings from our asymptomatic population of children in the absence of 
anti-malarial treatment are clear. The proportion of carriers of sub-microscopical 
gametocytes was approximately 60% contributing around 25% to the overall malaria 
transmission while carriers of gametocytes detectable by microscopy representing 33% and 
contributed 75% to overall transmission. In Kenya, children with sub-microscopical densities 
of gametocytes equally contributed to transmission compared to those with microscopically 
detectable gametocytes34. In our recent study including individuals of all ages (Ouedraogo 
and others, unpublished data) the proportion of carriers of submicroscopical and 
microscopical gametocytes were 49% and 16% respectively and contributed 51% and 47% to 
malaria transmission, respectively. In the study described in this thesis, the infectiousness of 
very low densities of gametocytes was evident although the proportion of infected 
mosquitoes was lower compared to higher gametocyte densities. Assuming that in a 
membrane feeding experiment with gametocyte carriers, fully fed mosquitoes engorged up 
to 2 L of blood (and all partially fed mosquitoes are discarded), the theoretic minimum 
density would be 1 gametocyte/ L: one male and one female gametocyte. In our 
experiments, mosquito infection occurred at densities estimated below 1 gametocyte/μL. 
Under laboratory conditions, the lowest gametocyte density from culture resulting in 
mosquito infections was in the range 250-300 gametocytes/mL34. In contrast, results from 
the field show infectious gametocyte densities below 100 gametocytes/mL34 and a few 
samples considered to be gametocyte negative by both microscopy and QT-NASBA (Chapter 
4) were even found to be infectious in Burkina Faso25 and Kenya34,35. In these cases, RNA 
degradation during sample collection or processing may explain why in mosquito infections 
from apparently gametocyte negative samples36 may still infect mosquitoes. From these 
combined data, it is evident that mosquito infections can occur at extremely low 
gametocyte densities. This phenomenon is very important, possibly explained by the 
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clustering of gametocytes in blood meal37 that may be influenced by adhesive ‘nanotubes38, 
thus requires further study in field and laboratory settings. RNA extraction controls show 
the potential disturbing influence of RNA degradation/failure to extract RNA.  
Importantly, we also observed that high gametocyte densities fail to infect mosquito. 
Although higher gametocyte densities favor mosquito infection28,34, a positive association 
with infectiousness is generally found to be weak22,39-42. There may be several explanations. 
Theoretically, only two gametocytes (male and female) in 2 L of blood meal are sufficiently  
to infect a single mosquito but the reality might be different under natural conditions. In 
individuals living in malaria endemic areas, the gametocyte sex ratio is female biased43-47 
with one male gametocyte for 3 to 4 female gametocytes26,48 but this ratio can vary 
significantly during the course of individual infections and may affect intra-individual 
transmission dynamics48,49. The non-infectiousness of high gametocyte densities may be 
related to this and/or reflect the presence of transmission reducing immunity that affects 
the success of transmission from man to mosquito50-56.   
 
7.3. The relevance of sexual stage immunity for the reduction of malaria 
transmission  
Immunity may act against gametocyte-derived antigens in the human circulation by 
reducing their density and / or infectiousness. In semi-immune individuals, a 3-fold 
reduction of P. falciparum gametocyte prevalence has been associated with non-specific 
anti-gametocyte antibodies30. Other studies further showed that naturally induced 
antibodies were capable of targeting younger stage I and IIa gametocytes against PfEMP1 
expressed on asexual and infected red blood cells57,58 but the functional relevance of this 
response in the field30 and in the lab remains elusive. Antibodies against gametocyte and 
gamete surface antigens59-61 can arrest the development of the sporogonic stage 
development in the mosquito midgut51,54-56,62,63, thereby reducing transmission from man to 
mosquito. This type of immunity may serve as a model for the development of transmission 
blocking vaccines and possibly could have an impact on malaria control efforts if it can be 
understood well. However, it is not sufficiently clear to which extent sexual stage immunity 
is present in individuals living in malaria endemic areas and affecting malaria transmission.  
 General discussion 
119 
 
We studied the acquisition of sexual stage immune responses in humans exposed to 
seasonal malaria transmission (Chapter 6). In a series of cross sectional surveys conducted 
at 3 month intervals at different points of the transmission season (start, peak and end). A 
lower proportion of sera showed detectable sexual stage serum antibodies (~28%) 
compared to asexual stage antibodies (54-65%) likely as a result of the lower prevalence of 
gametocyte carriers in the area (i.e. a relative lower exposure to gametocyte antigens 
compared to asexual parasite antigens). The development of immune responses against 
sexual stage antigens has previously been shown in longitudinal studies to be a function of 
recent rather than cumulative exposure to gametocytes64-66 suggesting that this type of 
immunity is possibly short lived requiring frequent boosting65-67 for sustained responses 
over a long period of time. Our study was not designed to monitor gametocyte exposure 
prior to blood sampling points, making it difficult to study the dynamics of sexual stage 
immune responses. In our cross-sectional surveys, we used two approaches to investigate 
the nature of sexual stage immune responses by: i) studying the age and season 
dependency, ii) comparing asexual and pre-erythrocytic immune responses to those against 
sexual stage antigens and iii) studying the relationship between concurrent gametocyte 
carriage and circulating sexual stage antibodies.   
Our data show that contrary to the age-related pattern of asexual and pre-erythrocytic 
antibody responses, an age-dependence in the development of sexual stage immune 
responses is not apparent. Despite the age-related increase of the seroprevalence for sexual 
stage antigens from children above 5 years, we found similar prevalences of sexual stage 
specific immune responses in youngest children and adults. This lack of age effect on sexual 
stage immune responses is not novel and has been attributed to their possible short 
immune memory. Similar to anti- GLURP antibodies generally found age51,68-72 but not 
season70,71related, sexual stage antibody responses could have increased with increasing 
age without considerable seasonal fluctuations if their immune memory was long-lived. In 
long-lived immune responses, antibody responses may reach a steady state after repeated 
exposure with long-lived plasma cells generating persisting antibody production. We do not 
observe any evidence for a consistent antibody production in older individuals. Instead, 
sexual stage immune responses show a seasonal response pattern that resembles that of 
short-lived pre-erythrocytic antibody responses.  
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NANP6 and Pfs230 immune responses are correlated in our analyses, possibly because both 
may depend on recent exposure to malaria antigen. It is also possible that the same 
individuals recently exposed to gametocytes were also recently exposed to sporozoite 
antigens (earlier in their recent infection). Recent exposure to gametocytes during the 
transmission season seems to occur in our study area where asexual parasite carriage is 
generally elevated at that time point21, and being associated with gametocytes9,35.  
Our data did not show an apparent relationship between the presence of sexual stage 
antibodies and concurrent gametocytaemias, in line with some51,73 but not all studies65. This 
lack of an association may be explained by the timing of sampling. Sexual stage antibodies 
induced before sampling may persist for several weeks after gametocyte clearance65 but 
may also be low when gametocytaemia is reduced to sub-microscopic levels, whilst its 
acquisition in the presence of gametocytes may take longer. This would indicate that the 
acquisition of sexual stage immune responses may be susceptible to recent50,64 rather than 
concurrent exposure to gametocytes. This is a limitation of the study design. Longitudinal 
studies will be required to plausibly address the issue of the induction of sexual stage 
immune responses in relation to antigen exposure. Our findings only provide indirect 
evidence for a short-lived nature of sexual stage immune responses. 
Although transmission reducing activity (TRA) was not measured in the same study, both 
Pfs230 and Pfs48/45 antigens have been acknowledged as targets of natural antibody 
responses51,53 that correlate with functional TRA49, 51,53,55,56. These natural antibodies 
mediating TRA have been found in gametocyte carriers in endemic areas34,52,54 and in 
individuals shortly after their first exposure to gametocytes, such as travelers or migrants 
from non endemic to endemic areas or children experiencing their first malaria infections 
55,56. In a recent study (Ouedraogo and others, unpublished data) conducted in the same 
area as the present study, 15% of sera were able to block/reduce malaria transmission from 
man to mosquito by 30-97% as measured in the standard membrane feeding assay.  
A positive and significant correlation is found between TRA and specific anti-Pfs48/45 
antibodies (Figure 2). In some cases, high antibody titers were not associated with blocking 
of transmission. A next step would be to determine the longevity of TRA in the area and to 
which extent transmission reducing immunity can be enhanced by transmission blocking 
vaccines. 
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Figure 2: Purified antibodies reduce man-mosquito transmission by 30-97% while TRA 
correlates (Spearman correlation = 024, p = 0.03) with Pfs48/45 antibody levels 
The dashed line represents the best fit for the association between Pfs48/45 antibody 
concentration and % oocyst reduction; % oocyst reduction = 100/1+10((3.673 - Pfs48/45 AU)*0.2517) 
 
7.4. Malaria control and future directions 
There is renewed interest in local malaria elimination leading toward more widespread 
eradication. This interest is encouraged by the recent declines observed in the incidence of 
clinical cases and deaths in some of sub-Saharan endemic countries74-78. Vector control tools 
such as LLINs and IRS can reduce transmission72,79 and the burden of  malaria80,81 and the 
WHO has justifiably called to scale up the use of these measures. However, neither vector 
control nor standard approaches to provide efficacious antimalarial drugs to symptomatic 
malaria cases have resulted in malaria elimination in any of the areas where they were 
employed, either alone or in combination. Additional tools that target the human side of 
malaria transmission are likely to be needed to interrupt the transmission cycle.  The great 
challenge is to clear the malaria parasites from populations or to reduce the transmission of 
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gametocytes from man to mosquito. Interventions that aim to prevent transmission require 
a thorough understanding of the human infectious reservoir. Most of the studies presented 
in this thesis can be seen in this light: increasing our understanding of the human infectious 
reservoir, its dynamics and factors influencing the association between asexual parasites, 
gametocytes, immune responses and malaria transmission to mosquitoes. Our findings 
indicate that the infectious reservoir comprises all age groups, symptomatic and 
asymptomatic parasite carriers harboring microscopic or submicroscopic gametocyte 
densities. This implies that transmission reducing interventions should target the whole 
population. The necessity for a high coverage is underlined by the basic reproduction 
number of malaria, which may be >100 in populations where malaria vectors are present 82. 
In other words, a single infectious individuals can cause dozens up to >100 secondary cases 
in a malaria-naïve population, for instance a population several years after successful 
malaria elimination82. Several interventions are available or will become available for 
malaria transmission control.  
 
Reducing the human gametocytaemic population  
Asymptomatic carriers of the parasite are important contributors to continuous malaria 
transmission and remain unaffected by conventional treatment approaches where drug 
administration is restricted to those with symptomatic malaria83. The efficacy of drug 
interventions will therefore depend on the proportion of parasite carriers that seek 
treatment. In situations where parasites are commonly carried asymptomatically, as was the 
case in all studies in this thesis, an alternative strategy is needed to include all parasite 
carriers. This strategy may comprise mass drug administration (MDA) where individuals 
receive a curative dose of antimalarials regardless of symptoms for parasite clearance3,84. 
Treatment of individuals with artemisinin derivatives should be recommended for this 
purpose because they effectively reduceor prevent young gametocyte stages, rapidly clear 
the asexual parasites from which gametocytes are derived and considerably reduce 
infectiousness after treatment compared to non-ACT treatment85,86. These interventions 
should be implemented at selected optimal periods. In seasonal malaria transmission 
settings, e.g. Burkina Faso, the optimal time of year for mass therapy to reduce the overall 
prevalence of asexual parasitaemia as an endpoint should be during the dry season87. 
Community interventions to target asymptomatic carriers can reduce the parasite 
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prevalence up to 75%  as reported recently 88-90. The predicted efficacy, optimal delivery 
strategy and drug of choice will depend on the transmission context. There is currently too 
little experience with MDA, especially in African settings, to judge the potential of this public 
health tool.  
 
Reducing the infectiousness of the malaria parasite 
A reduction in malaria transmission can also be achieved through the reduction of the 
parasite infectiousness. A malaria transmission blocking vaccine (MTBV) reduces the 
number of mosquitoes that are infected by a gametocytaemic vaccinated individual. As a 
consequence, an MTBV reduces the proportion of infected mosquitoes in a population and 
thereby the chance for individuals to become infected and the burden of disease91. 
Considerable progress has been made in the development of MTBV and several candidates 
are currently in the pipeline for clinical trials. Because MTBV targets are transmission stages 
that cause no clinical symptoms, they are generally considered altruistic with no personal 
benefit as they do not result in clinical protection for the vaccinee. At the public health level, 
a MTBV may be seen as advantageous since vaccinated individuals would lead to reductions 
in the reproduction rate of the parasite and in certain circumstances the spread of drug 
resistant parasite strains.  
The wide-spread nature of Plasmodium falciparum gametocytes described in this thesis and 
the contribution of very low gametocyte densities to transmission illustrate the importance 
of MTBV while the rapid induction of natural TRA in association with naturally acquired 
immune responses to sexual stage antigens illustrates its relevance to controlling malaria 
transmission in natural settings. Clearly, the benefits of such a vaccine would be enhanced 
when implemented in an integrated control strategy, although, as with any vaccine, issues 
such as the longevity of any immunity induced and the capacity for boosting of that 
immunity by naturally-acquired infection will affect its longer-term impact.  
 
References 
 
1.  Carter R, Mendis KN, Miller LH, Molineaux L, Saul A. Malaria transmission-blocking vaccines--
how can their development be supported? Nat Med 2000;6(3):241-4. 
2.  Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA. The epidemiology of 
Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol 
2006;22(9):424-30. 
 Chapter 7    
124 
 
3.  von Seidlein L, Walraven G, Milligan PJ, et al. The effect of mass administration of 
sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, 
community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg 
2003;97(2):217-25. 
4.  Akim NIJ, Drakely C, Kingo T, Simon B, Senkoro K, Sauerwein RW. Dynamics of P. falciparum 
gametocytemia in symptomatic patients in an area of intense perennial transmission in 
Tanzania. American Journal of Tropical Medicine and Hygiene 2000;63(3-4):199-203. 
5.  Bousema JT, Gouagna LC, Drakeley CJ, et al. Plasmodium falciparum gametocyte carriage in 
asymptomatic children in western Kenya. Malar J 2004;3(1):18. 
6.  Bruce MC, Alano P, Duthie S, Carter R. Commitment of the malaria parasite Plasmodium 
falciparum to sexual and asexual development. Parasitology 1990;100:191-200. 
7.  Price R, Nosten F, Simpson JA, et al. Risk factors for gametocyte carriage in uncomplicated 
falciparum malaria. Am J Trop Med Hyg 1999;60(6):1019-23. 
8.  Ouedraogo AL, Bousema T, de Vlas SJ, et al. The plasticity of Plasmodium falciparum 
gametocytaemia in relation to age in Burkina Faso. Malar J 2010;9:281. 
9.  Ouedraogo AL, Schneider P, de Kruijf M, et al. Age-dependent distribution of Plasmodium 
falciparum gametocytes quantified by Pfs25 real-time QT-NASBA in a cross-sectional study in 
Burkina Faso. Am J Trop Med Hyg 2007;76(4):626-30. 
10.  Abdel-Wahab A, Abdel-Muhsin AA, Ali E, et al. Dynamics of gametocytes among Plasmodium 
falciparum clones in natural infections in an area of highly seasonal transmission. Journal of 
Infectious Diseases 2002;185(12):1838-1842. 
11.  Drakeley CJ, Akim NI, Sauerwein RW, Greenwood BM, Targett GA. Estimates of the 
infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Trans 
R Soc Trop Med Hyg 2000;94(5):472-6. 
12.  Drakeley CJ, Carneiro I, Reyburn H, et al. Altitude-dependent and -independent variations in 
Plasmodium falciparum prevalence in northeastern Tanzania. J Infect Dis 2005;191(10):1589-
98. 
13.  Molineaux L, Gramiccia G. Parasitology, chapter five in "THE GARKI PROJECT. Research on 
the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa". WHO report 
1980:109-172. 
14.  van der Kolk M, Tebo AE, Nimpaye H, Ndombol DN, Sauerwein RW, Eling WM. Transmission 
of Plasmodium falciparum in urban Yaounde, Cameroon, is seasonal and age-dependent. 
Trans R Soc Trop Med Hyg 2003;97(4):375-9. 
15.  Boudin C, Lyannaz J, Bosseno MF, Carnevale P, Ambroise-Thomas P. Epidemiology of 
Plasmodium falciparum in a rice field and a savanna area in Burkina Faso: seasonal 
fluctuations of gametocytaemia and malarial infectivity. Ann Trop Med Parasitol 
1991;85(4):377-85. 
16.  Drakeley CJ, Secka I, Correa S, Greenwood BM, Targett GA. Host haematological factors 
influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae 
s.s. mosquitoes. Trop Med Int Health 1999;4(2):131-8. 
17.  Stepniewska K, Price RN, Sutherland CJ, et al. Plasmodium falciparum gametocyte dynamics 
in areas of different malaria endemicity. Malar J 2008;7:249. 
18.  Paul RE, Diallo M, Brey PT. Mosquitoes and transmission of malaria parasites - not just 
vectors. Malar J 2004;3:39. 
19.  Billingsley PF, Snook LS, Johnston VJ. Malaria parasite growth is stimulated by mosquito 
probing. Biol Lett 2005;1(2):185-9. 
20.  Shutler D, Reece SE, Mullie A, Billingsley PF, Read AF. Rodent malaria parasites Plasmodium 
chabaudi and P. vinckei do not increase their rates of gametocytogenesis in response to 
mosquito probing. Proc Biol Sci 2005;272(1579):2397-402. 
 General discussion 
125 
 
21.  Ouedraogo AL, de Vlas SJ, Nebie I, et al. Seasonal patterns of Plasmodium falciparum 
gametocyte prevalence and density in a rural population of Burkina Faso. Acta Trop 
2008;105(1):28-34. 
22.  Boudin C, Olivier M, Molez JF, Chiron JP, Ambroise-Thomas P. High human malarial 
infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Am J Trop Med 
Hyg 1993;48(5):700-6. 
23.  Cattani JA, Tulloch JL, Vrbova H, et al. The epidemiology of malaria in a population 
surrounding Madang, Papua New Guinea. American Journal of Tropical Medicine and 
Hygiene 1986;35(1):3-15. 
24.  Bousema T, Okell L, Shekalaghe S, et al. Revisiting the circulation time of Plasmodium 
falciparum gametocytes: molecular detection methods to estimate the duration of 
gametocyte carriage and the effect of gametocytocidal drugs. Malar J 2010;9:136. 
25.  Eichner M, Diebner HH, Molineaux L, Collins WE, Jeffery GM, Dietz K. Genesis, sequestration 
and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a 
model to malariatherapy data. Trans R Soc Trop Med Hyg 2001;95(5):497-501. 
26.  Sinden RE. Sexual development of malarial parasites. Adv Parasitol 1983;22:153-216. 
27.  Drakeley CJ, Flobbe K, Greenwood BM, Targett GA. Plasmodium falciparum gametocytes in 
Gambian adults. Ann Trop Med Parasitol 2000;94(4):399-401. 
28.  Tchuinkam T, Mulder B, Dechering K, et al. Experimental infections of Anopheles gambiae 
with Plasmodium falciparum of naturally infected gametocyte carriers in Cameroon: factors 
influencing the infectivity to mosquitoes. Trop Med Parasitol 1993;44(4):271-6. 
29.  Taylor LH, Read AF. Why so few transmission stages? Reproductive restraint by malaria 
parasites. Parasitol Today 1997;13(4):135-40. 
30.  Baird JK, Jones TR, Purnomo, Masbar S, Ratiwayanto S, Leksana B. Evidence for specific 
suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian 
Jaya. Am J Trop Med Hyg 1991;44(2):183-90. 
31.  Schneider P, Schoone G, Schallig H, et al. Quantification of Plasmodium falciparum 
gametocytes in differential stages of development by quantitative nucleic acid sequence-
based amplification. Mol Biochem Parasitol 2004;137(1):35-41. 
32.  Schoone GJ, Oskam L, Kroon NCM, Schallig HDFH, Omar SA. Detection and quantification of 
Plasmodium falciparum in blood samples using quantitative nucleic acid sequence-based 
amplification. Journal of Clinical Microbiology 2000;38(1):4072-4075. 
33.  Shekalaghe SA, Bousema JT, Kunei KK, et al. Submicroscopic Plasmodium falciparum 
gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. 
Trop Med Int Health 2007;12(4):547-53. 
34.  Schneider P, Bousema JT, Gouagna LC, et al. Submicroscopic Plasmodium falciparum 
gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg 
2007;76(3):470-4. 
35.  Ouedraogo AL, Bousema T, Schneider P, et al. Substantial contribution of submicroscopical 
Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of 
seasonal transmission. PLoS One 2009;4(12):e8410. 
36.  Bousema JT. Interrupting malaria transmission: the effects of drugs and immunity on the 
transmissibility of Plasmodium falciparum. Thesis Radboud University Nijmegen:1. 2007. 
37.  Pichon G, Awono-Ambene HP, Robert V. High heterogeneity in the number of Plasmodium 
falciparum gametocytes in the bloodmeal of mosquitoes fed on the same host. Parasitology 
2000;121 (Pt 2):115-20. 
38.  Rupp I, Sologub L, Williamson KC, et al. Malaria parasites form filamentous cell-to-cell 
connections during reproduction in the mosquito midgut. Cell Res 2010. 
39.  Graves PM. Studies on the use of a membrane feeding technique for infecting Anopheles 
gambiae with Plasmodium falciparum. Trans R Soc Trop Med Hyg 1980;74(6):738-42. 
 Chapter 7    
126 
 
40.  Graves PM, Burkot TR, Carter R, et al. Measurement of malarial infectivity of human 
populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology 1988;96 
(Pt 2):251-63. 
41.  Muirhead-Thomson RC. Low gametocyte thresholds of infection of Anopheles with 
Plasmodium falciparum; a significant factor in malaria epidemiology. Br Med J 1954;4853:68-
70. 
42.  Mulder B, Tchuinkam T, Dechering K, et al. Malaria transmission-blocking activity in 
experimental infections of Anopheles gambiae from naturally infected Plasmodium 
falciparum gametocyte carriers. Trans R Soc Trop Med Hyg 1994;88(1):121-5. 
43.  Read AF, Narara A, Nee S, Keymer AE, Day KP. Gametocyte sex ratios as indirect measures of 
outcrossing rates in malaria. Parasitology 1991;104:387-395. 
44.  Robert V, Boudin C. [Biology of man-mosquito Plasmodium transmission]. Bull Soc Pathol 
Exot 2003;96(1):6-20. 
45.  Robert V, Read AF, Essong J, et al. Effect of gametocyte sex ratio on infectivity of 
Plasmodium falciparum to Anopheles gambiae. Trans R Soc Trop Med Hyg 1996;90(6):621-4. 
46.  Sowunmi A, Balogun ST, Gbotosho GO, Happi CT. Plasmodium falciparum gametocyte sex 
ratios in symptomatic children treated with antimalarial drugs. Acta Trop 2009;109(2):108-
17. 
47.  Sowunmi A, Gbotosho GO, Happi CT, Folarin OA, Balogun ST. Population structure of 
Plasmodium falciparum gametocyte sex ratios in malarious children in an endemic area. 
Parasitol Int 2009;58(4):438-43. 
48.  Paul REL, Coulson TN, Raibaud A, Brey PT. Sex determination in malaria parasites. Science 
2000;287:128-131. 
49.  Robert V, Sokhna CS, Rogier C, Ariey F, Trape JF. Sex ratio of Plasmodium falciparum 
gametocytes in inhabitants of Dielmo, Senegal. Parasitology 2003;127(Pt 1):1-8. 
50.  Bousema T, Sutherland CJ, Churcher TS, et al. Human immune responses that reduce the 
transmission of Plasmodium falciparum in African populations. Int J Parasitol. 
51.  Drakeley CJ, Bousema JT, Akim NI, et al. Transmission-reducing immunity is inversely related 
to age in Plasmodium falciparum gametocyte carriers. Parasite Immunol 2006;28(5):185-90. 
52.  Healer J, McGuinness D, Carter R, Riley E. Transmission-blocking immunity to Plasmodium 
falciparum in malaria-immune individuals is associated with antibodies to the gamete 
surface protein Pfs230. Parasitology 1999;119 (Pt 5):425-33. 
53.  Mendis KN, Munesinghe YD, de Silva YN, Keragalla I, Carter R. Malaria transmission-blocking 
immunity induced by natural infections of Plasmodium vivax in humans. Infect Immun 
1987;55(2):369-72. 
54.  Roeffen W, Geeraedts F, Eling W, et al. Transmission blockade of Plasmodium falciparum 
malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect Immun 
1995;63(2):467-71. 
55.  Roeffen W, Mulder B, Teelen K, et al. Association between anti-Pfs48/45 reactivity and P. 
falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunol 
1996;18(2):103-9. 
56.  van der Kolk M, de Vlas SJ, Sauerwein RW. Reduction and enhancement of Plasmodium 
falciparum transmission by endemic human sera. Int J Parasitol 2006;36(10-11):1091-5. 
57.  Piper KP, Hayward RE, Cox MJ, Day KP. Malaria transmission and Naturally acquired 
immunity to PfEMP-1. Infection and Immunity 1999;67(12):6369-6374. 
58.  Saeed M, Roeffen W, Alexander N, Drakeley CJ, Targett GA, Sutherland CJ. Plasmodium 
falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS One 
2008;3(5):e2280. 
59.  Kumar N. Target antigens of malaria transmission blocking immunity exist as a stable 
membrane bound complex. Parasite Immunol 1987;9(3):321-35. 
 General discussion 
127 
 
60.  Vermeulen AN, Ponnudurai T, Beckers PJ, Verhave JP, Smits MA, Meuwissen JH. Sequential 
expression of antigens on sexual stages of Plasmodium falciparum accessible to 
transmission-blocking antibodies in the mosquito. J Exp Med 1985;162(5):1460-76. 
61.  Vermeulen AN, Roeffen WF, Henderik JB, Ponnudurai T, Beckers PJ, Meuwissen JH. 
Plasmodium falciparum transmission blocking monoclonal antibodies recognize 
monovalently expressed epitopes. Dev Biol Stand 1985;62:91-7. 
62.  Bousema JT, Drakeley CJ, Sauerwein RW. Sexual-stage antibody responses to P. falciparum in 
endemic populations. Curr Mol Med 2006;6(2):223-9. 
63.  Graves PM, Wirtz RA, Carter R, Burkot TR, Looker M, Targett GA. Naturally occurring 
antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal 
antibody-based competitive enzyme-linked immunosorbent assay. Infect Immun 
1988;56(11):2818-21. 
64.  Bousema JT, Roeffen W, van der Kolk M, et al. Rapid onset of transmission-reducing 
antibodies in javanese migrants exposed to malaria in papua, indonesia. Am J Trop Med Hyg 
2006;74(3):425-31. 
65.  Bousema T, Roeffen W, Meijerink H, et al. The dynamics of naturally acquired immune 
responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low 
endemic area in Tanzania. PLoS One;5(11):e14114. 
66.  Ranawaka MB, Munesinghe YD, de Silva DM, Carter R, Mendis KN. Boosting of transmission-
blocking immunity during natural Plasmodium vivax infections in humans depends upon 
frequent reinfection. Infect Immun 1988;56(7):1820-4. 
67.  Mendis KN, David PH, Carter R. Human immune responses against sexual stages of malaria 
parasites: considerations for malaria vaccines. Int J Parasitol 1990;20(4):497-502. 
68.  Cohen S, Butcher GA. Serum antibody in acquired malarial immunity. Trans R Soc Trop Med 
Hyg 1971;65(2):125-35. 
69.  Cohen S, Butcher GA, Mitchell GH, Deans JA, Langhorne J. Acquired immunity and 
vaccination in malaria. Am J Trop Med Hyg 1977;26(6 Pt 2):223-32. 
70.  Dodoo D, Theisen M, Kurtzhals JA, et al. Naturally acquired antibodies to the glutamate-rich 
protein are associated with protection against Plasmodium falciparum malaria. J Infect Dis 
2000;181(3):1202-5. 
71.  Dziegiel M, Rowe P, Bennett S, et al. Immunoglobulin M and G antibody responses to 
Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in 
Gambian children. Infect Immun 1993;61(1):103-8. 
72.  Molineaux L, Gramiccia G. THE GARKI PROJECT. Research on the Epidemiology and 
Control of Malaria in the Sudan Savanna of West Africa. WHO report 1980:311. 
73.  Bousema JT, Drakeley CJ, Kihonda J, et al. A longitudinal study of immune responses to 
Plasmodium falciparum sexual stage antigens in Tanzanian adults. Parasite Immunol 
2007;29(6):309-17. 
74.  Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, et al. Evidence of decline of malaria in 
the general hospital of Libreville, Gabon from 2000 to 2008. Malar J 2009;8(1):300. 
75.  Ceesay SJ, Casals-Pascual C, Erskine J, et al. Changes in malaria indices between 1999 and 
2007 in The Gambia: a retrospective analysis. Lancet 2008;372(9649):1545-54. 
76.  Muller O, Ye M, Louis VR, Sie A. Malaria in sub-Saharan Africa. Lancet 2009;373(9658):122. 
77.  Okiro EA, Hay SI, Gikandi PW, et al. The decline in paediatric malaria admissions on the coast 
of Kenya. Malar J 2007;6:151. 
78.  O'Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in 
sub-Saharan Africa. Lancet Infect Dis 2010;10(8):545-55. 
79.  Killeen GF, Smith TA, Ferguson HM, et al. Preventing childhood malaria in Africa by 
protecting adults from mosquitoes with insecticide-treated nets. PLoS Med 2007;4(7):e229. 
80.  Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane 
Database Syst Rev 2004(2):CD000363. 
 Chapter 7    
128 
 
81.  Sharp BL, Kleinschmidt I, Streat E, et al. Seven years of regional malaria control 
collaboration--Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 2007;76(1):42-
7. 
82.  Smith DL, McKenzie FE, Snow RW, Hay SI. Revisiting the basic reproductive number for 
malaria and its implications for malaria control. PLoS Biol 2007;5(3):e42. 
83.  Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC. Modelling the impact of artemisinin 
combination therapy and long-acting treatments on malaria transmission intensity. PLoS 
Med 2008;5(11):e226; discussion e226. 
84.  Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on 
islands. Lancet 2000;356(9241):1560-4. 
85.  Bousema JT, Schneider P, Gouagna LC, et al. Moderate effect of artemisinin-based 
combination therapy on transmission of Plasmodium falciparum. J Infect Dis 
2006;193(8):1151-9. 
86.  Sutherland CJ, Ord R, Dunyo S, et al. Reduction of malaria transmission to Anopheles 
mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2005;2(4):e92. 
87.  Shekalaghe S. Reducing malaria transmission in low endemic areas in tanzania by 
antimalarial drugs: Epidemiological and Intervention Studies. Thesis Radboud University 
Nijmegen:1. 2010. 
88.  Dicko A, Diallo AI, Tembine I, et al. Intermittent Preventive Treatment of Malaria Provides 
Substantial Protection against Malaria in Children Already Protected by an Insecticide-
Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial. PLoS Med 
2011;8(2):e1000407. 
89.  Konate AT, Yaro JB, Ouedraogo AZ, et al. Intermittent Preventive Treatment of Malaria 
Provides Substantial Protection against Malaria in Children Already Protected by an 
Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled 
Trial. PLoS Med 2011;8(2):e1000408. 
90.  Schellenberg D, Menendez C, Aponte JJ, et al. Intermittent preventive antimalarial treatment 
for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. 
Lancet 2005;365(9469):1481-3. 
91.  Sauerwein RW. Malaria transmission-blocking vaccines: the bonus of effective malaria 
control. Microbes Infect 2007;9(6):792-5. 
 
  
 
 
 
 
                                                                                     Chapter 8 
 
 
Summary 
Résumé 
Samenvatting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 8 
130 
 
Summary 
 
Malaria is the most frequent parasitic disease affecting humans around the globe. 
Amongst the five species of Plasmodium responsible for human malaria, Plasmodium 
falciparum is the most pathogenic, causing up to 800,000 deaths per year. The parasite life 
cycle comprises several developmental stages. Asexual blood stage parasites multiply in red 
blood cells, causing clinical disease. Sexual stage parasites, called gametocytes, develop 
within red blood cells from a small proportion of asexual blood stage parasites but they do 
not cause symptoms and are exclusively responsible for transmitting the infection to female 
anopheline mosquitoes during blood feeding. Infected mosquitoes can in turn infect other 
humans during subsequent feeds. Although efforts are being made to target sexual stages 
as part of an integrated malaria control strategy, the extent of the human reservoir of 
gametocytes is poorly defined, representing a major obstacle to the future success of such 
efforts.   
This thesis aimed to accurately quantify gametocytes in humans and to investigate 
their infectiousness under natural conditions, in order to contribute to our understanding of 
the biology of malaria transmission, as well as to inform control strategists about the best 
way to target gametocytes in the context of malaria control. For this purpose, we designed 
our studies to determine: i) age-specific and temporal changes in gametocyte prevalence 
(Chapter 2, 3&4); ii) the contribution of sub-microscopic gametocyte densities to the human 
infectious reservoir (Chapter 5) and iii) the dynamics of naturally acquired transmission-
reducing immunity (Chapter 6).  
Our findings show that microscopically detectable gametocyte concentrations are most 
prevalent in children and during the wet season. This is primarily due to the higher asexual 
parasite densities found both in children and in the wet season, although we found 
indications that human and mosquito immune factors may also play a role (Chapter 2). The 
use of the molecular QT-NASBA technique, a much more sensitive method than microscopy 
for detecting low gametocyte concentrations, indicates that gametocyte prevalence is 3.3 
fold higher (70%) than estimated based on microscopy (17%), revealing the widespread 
occurrence of sub-microscopic gametocyte densities not only in children but also in 
asymptomatic adults (Chapter 3). Since gametocyte occurrence seems to be positively 
related to high densities of asexual parasites, it is surprising that sub-microscopic 
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gametocytes are highly prevalent in adults, who commonly harbour low asexual parasite 
densities. This paradox is explored in more detail in Chapter 4 of this thesis where we 
describe increased gametocyte production rates in adults. The proportion of gametocytes 
relative to the total parasite population increases with age, suggesting that gametocyte 
commitment may be higher in adults. From an evolutionary point of view, this would be an 
advantageous strategy for parasites: if acquired human immunity reduces asexual parasite 
growth rates, parasites increase their investment in gametocytes to maximize the chance of 
transmission to mosquitoes.  Although transmission success is positively associated with 
gametocyte density, we showed that low gametocyte densities are nevertheless highly 
efficient in transmitting the infection. The contribution of sub-microscopic gametocytes to 
the infectious reservoir is found to be substantial (Chapter 5). Although low density 
gametocytaemias result in a lower proportion of infected mosquitoes, their relevance for 
malaria transmission is compensated for by their high frequency in the whole population. As 
a consequence, the overall contribution of sub-microscopic gametocyte densities to malaria 
transmission is approximately 25%. These findings on gametocyte infectiousness are derived 
from children and cannot therefore be extrapolated to the whole population. However, 
older age-groups should not be seen as having negligible responsibility for malaria 
transmission as they represent a substantial proportion of the general population and they 
harbour a remarkably high prevalence of (low density) gametocytes.  
Despite efficient malaria transmission in our study area, gametocytes from our volunteers’ 
blood samples were not always infectious to mosquitoes in experimental feeding assays. 
Their infectiousness may be affected by factors including naturally acquired transmission-
reducing immunity. In Chapter 6, we show that antibody responses against transmission 
blocking vaccine candidate antigens are naturally acquired in our study population and that 
their induction is a function of recent rather than cumulative exposure to malaria. These 
immune responses are not necessarily highest in adults and may reduce man-to-mosquito 
transmission by preventing the fertilization and development of the parasite in the 
mosquito midgut.  
In conclusion, the work from this thesis reveals an age- and season-structured 
allocation of gametocytes with a high prevalence and relevance of sub-microscopic 
gametocyte densities. Whilst immune responses to sexual stage antigens are naturally 
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acquired in the study populations, transmission is efficiently maintained. This emphasizes 
the need for malaria transmission control strategies to reduce malaria transmission and 
ultimately the burden of malaria disease.  
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Résumé 
 
Le paludisme demeure la parasitose la plus fréquente affectant l’homme. Des cinq 
espèces responsable du paludisme humain, Plasmodium falciparum est la plus 
pathogénique responsable d’au moins 800 000 décès par an. Le cycle du parasite comprend 
plusieurs formes parasitaires parmi lesquelles la forme asexuée dont la multiplication au 
sein des globules rouges provoque les manifestations cliniques de la maladie. Les formes 
sexuées, encore appelés gamétocytes sont produites chez l’hôte humain à partir d’une 
petite proportion de formes asexuées. Contrairement aux formes asexuées, les gamétocytes 
ne causent pas de symptômes et sont exclusivement responsables de la transmission de 
l’infection à Anophèles femelle lors de la prise de son repas sanguin. Le moustique infecté 
peut ainsi en retour infecter d’autres êtres humains lors de ses prochains repas sanguin. 
Quoique à travers de nombreux programmes intégrés de control du paludisme, des efforts 
sont entrepris pour éliminer les gamétocytes, le manque de clarté sur l’étendu du réservoir 
humain de gamétocytes constitue un obstacle majeur quand à l’efficacité de tels efforts. 
La présente thèse avait pour but de déterminer l’étendu du réservoir de 
gamétocytes chez l’homme et d’évaluer leur infectivité dans des conditions naturelles afin 
de collecter et rendre disponible des informations utiles aux stratégies de control du 
paludisme et éventuellement à son élimination. Pour cela, nous avons planifier nos activités 
de recherche comme suit afin de : i) déterminer les variations des taux de portage 
gamétocytaire sous l’effet de l’âge et de la saison (Chapitre 2, 3&4); ii) déterminer la 
contribution des faibles densités de gamétocytes au réservoir infectieux (Chapitre 5) et enfin 
iii) étudier la dynamique de l’immunité naturelle acquise réduisant la transmission du 
paludisme (Chapitre 6).  
Nos résultats montrent que les gamétocytes quantifiés par la microscopie sont assez 
prévalentes chez l’enfant mais aussi pendant la saison de pluie. Cette observation 
s'expliquerait par la presence de fortes densités de parasites asexués chez l’enfant et 
pendant la saison de pluie quoique nos résultats laissent croire que des facteurs 
immunitaires chez l’homme et le vecteur puissent jouer un rôle (Chapitre 2). L’utilisation de 
la technique QT-NASBA, une technique moléculaire plus sensible que la microscopie, 
montre que la prévalence des gamétocytes était 3,3 fois plus élevée (70%) que celle basée 
sur la microscopie (17%) révélant ainsi une forte fréquence de faibles densités 
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gamétocytaires chez l’enfant mais aussi chez l’adulte (Chapitre 3). Cette observation nous 
est plutôt apparue surprenant vue que les fortes densités de parasites asexués, favorables à 
la production de gamétocytes, sont moins fréquentes chez l’adulte. En étudiant le 
phénomène de plus près dans le Chapitre 4, nous avons observé une augmentation de la 
production gamétocytaire chez l’adulte à partir de faibles densités de parasites asexués. 
Effectivement, dans ce Chapitre 4, nous montrons que la proportion de gamétocytes 
relative à la population totale de parasites augmentait avec l’âge, ce qui suggère que la 
faculté du parasite asexué à se transformer en parasite sexué augmente avec l’âge de 
l’individu. D’un point de vu évolutif, il pourrait s’agir d’une stratégie de survie pour le 
parasite. En effet, le parasite asexué gagnerait pour sa survie en se transformant en parasite 
sexuée pour être transferré chez le moustique plutôt que de subir une réduction de son 
taux de multiplication sous une pression stressante chez l’adulte.  
Alors qu’une forte densité gamétocytaire apparait être un facteur clé pour la transmission  
home-moustique, nous montré au Chapitre 5 que les faibles densités de gamétocytes 
pouvaient aussi être efficaces pour transmettre l’infection au moustique.  Même si les 
individus porteurs de faibles gametocytémies infectent moins de moustiques, ils restent 
importants pour la transmission du paludisme car leur proportion dans la population 
générale est assez importante à tel point que leur part de contribution au réservoir 
infectieux avoisinerait les 25%. Ces résultats ne peuvent être extrapolés à toute la 
population car provenant de données receuillies seulement au sein d’une population 
d’enfants. Cependant il est prudent de souligner que les individus plus âgés ne sont pas à 
négliger en matière de transmission du paludisme vue leur représentativité dans la 
population et leur forte susceptibilité à porter des gamétocytes quoique de faible densité.  
 
Malgré une transmission intense observée dans notre zone d’étude, nous montrons 
que des échantillons de sang infectés de gamétocytes n’étaient pas toujours infectieux lors 
de nos séances d’infection expérimentales de moustiques. En effet, l’infectivité du 
gamétocyte est sujet à des facteurs dont l’immunité naturelle réduisant la transmission. Au 
Chapitre 6, nous montrons que des anticorps dirigées contre des antigènes candidats au 
vaccin bloquant la transmission du paludisme étaient naturellement acquises dans notre 
population d’étude. Nous montrons que ce type d’immunité se développe à la suite d’une 
exposition récente aux gamétocytes plutôt qu’à une exposition répétée et prolongée. Cette 
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réponse immunitaire est plutôt similaire à  celle observée chez les individus plus âgés et est 
susceptible de réduire la transmission homme-moustique en prévenant la fécondation et le 
développement des formes sexuées du parasite chez le moustique.    
 
Pour conclure, le travail décrit dans cette thèse met en exergue l’existence d’une 
allocation structurée des gamétocytes en fonction de l’âge et de la saison ainsi qu’une 
fréquence importante des gamnetocytémies non détectables par la microscopie. Malgré 
qu’une immunité anti-gamétocytes soit naturellement acquise dans les populations, nous 
constatons que la transmission du paludisme est remarquablement efficace et continue. 
Cela démontre quel à point il y a un besoin urgent de stratégies visant à réduire la 
transmission et conséquemment le fardeau de la maladie.  
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Samenvatting 
 
Malaria is wereldwijd één van de meest voorkomende parasitaire ziekten bij de 
mens. Van de vijf Plasmodium species die verantwoordelijk zijn voor malaria in de mens, is 
Plasmodium falciparum de meest gevaarlijke, met 800.000 doden per jaar. De levenscyclus 
van de parasiet bestaat uit verschillende ontwikkelingsstadia. Aseksuele bloedstadium 
parasieten vermenigvuldigen zich in rode bloedcellen en veroorzaken de symptomen die 
leiden tot klinische ziekte. Seksueel stadium parasieten, ook wel gametocyten genoemd, 
ontwikkelen zich in de rode bloedcel uit een klein deel van de aseksuele bloedstadia. Deze 
gametocyten veroorzaken geen symptomen maar zijn verantwoordelijk voor de transmissie 
van de parasiet van mens naar de vrouwelijke anopheles mug. Met een nieuw bloedmaal 
brengen deze geïnfecteerde muggen de parasiet weer over op de mens. Slechts weinig is 
bekend over het humane reservoir van gametocyten, ondanks vele inspanningen om het 
seksuele stadium gericht te bestrijden als onderdeel van een geïntegreerde malaria controle 
strategie. Het gebrek aan kennis beperkt het toekomstig succes van deze dergelijke 
strategieën. 
 
Het doel van dit proefschrift is het kwantificeren van de gametocyten in de mens en 
te onderzoeken hoe infectieus deze zijn in natuurlijke omstandigheden. Onze bevindingen 
dragen bij aan een beter inzicht in de biologie van malaria transmissie en aan betere 
controle strategieën voor de aanpak van gametocyten in the context van malaria controle of 
eliminatie. Wij hebben in onze studies daarom het volgende onderzocht: i) 
leeftijdsspecifieke en tijdelijke veranderingen in gametocyt prevalentie (hoofdstuk 2,3,4); ii) 
de bijdrage van submicroscopische gametocytemie aan het totale humane infectieuze 
reservoir (hoofdstuk 5) en iii) de dynamiek van natuurlijk verkregen transmissie 
reducerende immuniteit (hoofdstuk 6). 
 
Uit onze resultaten blijkt dat het dragen van microscopisch detecteerbare 
gametocyten vooral voorkomt bij kinderen en tijdens het regenseizoen. Dit is voornamelijk 
het gevolg van hogere concentraties aseksuele parasieten. Wij vonden echter ook 
aanwijzingen dat immuun factoren van mens en mug hierin een rol spelen (hoofdstuk 2). 
Voor onze onderzoeken maakten wij gebruik van de moleculaire QT-NASBA techniek, een 
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methode die veel sensitiever gametocyten detecteert dan microscopie. Hiermee laten wij 
zien dat de gametocyt prevalentie 3.3 maal zo hoog is als schattingen gebaseerd op 
microscopie (70% versus 17%). Dit toont het wijdverspreide voorkomen van 
submicroscopische gametocyten aan, niet alleen in kinderen maar ook in asymptomatische 
volwassenen (hoofdstuk 3). Ondanks de positieve relatie tussen aseksuele parasitemie en 
gametocyten dichtheid, hebben volwassenen, met gewoonlijk lage aantallen aseksuele 
parasieten, vaak submicroscopische gametocyten. Deze paradox wordt in hoofdstuk 4 in dit 
proefschrift meer uitgewerkt waarin wij een verhoogde gametocyt productie in 
volwassenen beschrijven. De verhouding tussen gametocyten en de totale hoeveelheid 
parasieten verhoogt met oudere leeftijd, wat suggereert dat sexuele differentiatiedruk 
sterker is in volwassenen. Evolutionair gezien zou dit een overlevingsstrategie van de 
parasiet zijn: als door verworven immuniteit het aantal aseksuele parasieten in volwassenen 
verlaagt, verhoogt de parasiet zijn investering in gametocyten, om zijn transmissiekansen te 
verhogen. Hoewel transmissiesucces positief geassocieerd is met gametocyt concentratie, 
hebben wij aangetoond dat lage gametocyt concentraties bijzonder infectieus zijn. Hoewel 
een lage gametocytemie zorgt voor relatief weinig geïnfecteerde muggen, is het voorkomen 
hiervan relevant voor malaria transmissie vanwege de grote aantallen gametocytendragers. 
De bijdrage van submicroscopische gametocyten aan het totaal infectieuze reservoir is dus 
substantieel (hoofdstuk 5) met een totale bijdrage aan malaria transmissie van ongeveer 
25%. Bovenstaand onderzoek is enkel verricht in kinderen waardoor de resultaten niet 
direct geëxtrapoleerd kunnen worden naar de gehele populatie. Echter, oudere 
leeftijdsgroepen zijn een niet te verwaarlozen factor in malaria transmissie omdat deze een 
groot deel van de gehele populatie uitmaken en een opvallend vaak submicroscopische 
gametocytemie hebben. 
 
De gametocyten afkomstig uit bloedmonsters van onze vrijwilligers waren niet altijd 
infectieus voor muggen in experimentele voedingsassays, ondanks een efficiënte malaria 
transmissie in ons studiegebied. De besmettelijkheid kan door verschillende factoren zijn 
verlaagd, zoals door natuurlijk verworven transmissie reducerende immuniteit. In hoofstuk 
6 laten we zien dat antilichaam reacties tegen transmissie blokkerende vaccine kandidaat 
antigenen in onze studiepopulatie natuurlijk verworven worden. De immuun responsen 
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verlagen de transmissie van mens naar mug door het voorkomen van bevruchting en 
ontwikkeling van de parasiet in de muggenmaag. Deze responses zijn niet altijd het hoogst 
in volwassenen en inductie van de responsen is meer een functie van recente blootstelling 
dan een cumulatieve blootstelling aan malaria. 
 
Concluderend laat dit proefschrift een leeftijds- en seizoens afhankelijke 
gametocytemie zien met een belangrijke rol voor submicroscopische gametocyt 
concentraties. Ondanks natuurlijk verworven immuniteit tegen seksuele antigenen bleef de 
transmissie behouden in de onderzoekspopulaties. Dit benadrukt de noodzaak voor 
controle strategieën die malaria transmissie en daarmee malaria morbiditeit reduceren. 
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